View Filing Data

Print Document View Excel Document

Document And Entity Information - USD ($) $ in Thousands	12 Months Ended
Document And Entity Information - USD ($) $ in Thousands	Jun. 30, 2017	Sep. 06, 2017	Dec. 31, 2016
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	FY
Trading Symbol	HAIN
Entity Registrant Name	HAIN CELESTIAL GROUP INC.
Entity Central Index Key	0000910406
Current Fiscal Year End Date	--06-30
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		103,719,173
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 3,970,465

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
Current assets:
Cash and cash equivalents	$ 146,992	$ 127,926
Accounts receivable, less allowance for doubtful accounts of $1,447 and $936, respectively	248,436	278,933
Inventories	427,308	408,564
Prepaid expenses and other current assets	52,045	84,811
Total current assets	874,781	900,234
Property, plant and equipment, net	370,511	389,841
Goodwill	1,059,981	1,060,336
Trademarks and other intangible assets, net	573,268	604,787
Investments and joint ventures	18,998	20,244
Other assets	33,565	32,638
Total assets	2,931,104	3,008,080
Current liabilities:
Accounts payable	222,136	251,712
Accrued expenses and other current liabilities	108,514	78,803
Current portion of long-term debt	9,844	26,513
Total current liabilities	340,494	357,028
Long-term debt, less current portion	740,304	836,171
Deferred income taxes	121,475	131,507
Other noncurrent liabilities	15,999	18,860
Total liabilities	1,218,272	1,343,566
Commitments and contingencies (Note 15)
Stockholders’ equity:
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none	0	0
Common stock - $.01 par value, authorized 150,000 shares; issued: 107,989 and 107,479 shares, respectively; outstanding: 103,702 and 103,461 shares, respectively	1,080	1,075
Additional paid-in capital	1,137,724	1,123,206
Retained earnings	868,822	801,392
Accumulated other comprehensive loss	(195,479)	(172,111)
Total stockholders' equity including treasury stock	1,812,147	1,753,562
Less: Treasury stock, at cost, 4,287 and 4,018 shares, respectively	(99,315)	(89,048)
Total stockholders’ equity	1,712,832	1,664,514
Total liabilities and stockholders’ equity	$ 2,931,104	$ 3,008,080

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts (in dollars)	$ 1,447	$ 936
Preferred stock, par value (USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	107,989,000	107,479,000
Common stock, shares, outstanding	103,702,000	103,461,000
Treasury stock, shares	4,287,000	4,018,000

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Income Statement [Abstract]
Net sales	$ 2,853,111	$ 2,885,374	$ 2,609,613
Cost of sales	2,311,739	2,271,243	2,046,758
Gross profit	541,372	614,131	562,855
Selling, general and administrative expenses	331,763	303,763	302,827
Amortization of acquired intangibles	18,402	18,869	17,846
Acquisition related expenses, restructuring and integration charges	10,388	13,391	7,316
Accounting review costs	29,562	0	0
Goodwill impairment	0	84,548	0
Long-lived asset and intangibles impairment	40,452	43,200	1,004
Operating income	110,805	150,360	233,862
Interest and other financing expense, net	21,274	25,161	25,973
Other (income)/expense, net	388	16,543	4,689
Gain on sale of business	0	0	(9,669)
Gain on fire insurance recovery	0	(9,752)	0
Income before income taxes and equity in earnings of equity-method investees	89,143	118,408	212,869
Provision for income taxes	21,842	70,932	48,535
Equity in net loss (income) of equity-method investees	(129)	47	(628)
Net income	$ 67,430	$ 47,429	$ 164,962
Net income per common share:
Basic (USD per share)	$ 0.65	$ 0.46	$ 1.62
Diluted (USD per share)	$ 0.65	$ 0.46	$ 1.60
Shares used in the calculation of net income per common share:
Basic (shares)	103,611	103,135	101,703
Diluted (shares)	104,248	104,183	103,421

Consolidated Statements of Comprehensive Income (Loss) Statement - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Statement of Comprehensive Income [Abstract]
Net income	$ 67,430	$ 47,429	$ 164,962
Pre-tax amount
Foreign currency translation adjustments	(22,951)	(129,874)	(106,790)
Change in deferred gains (losses) on cash flow hedging instruments	(411)	(788)	2,093
Change in unrealized gain (loss) on available for sale investment	(53)	(129)	(1,575)
Total other comprehensive (loss) income	(23,415)	(130,791)	(106,272)
Tax (expense) benefit
Foreign currency translation adjustments	0	0	4,416
Change in deferred gains (losses) on cash flow hedging instruments	32	261	(512)
Change in unrealized gain (loss) on available for sale investment	15	50	669
Total other comprehensive (loss) income	47	311	4,573
After-tax amount
Foreign currency translation adjustments	(22,951)	(129,874)	(102,374)
Change in deferred gains (losses) on cash flow hedging instruments	(379)	(527)	1,581
Change in unrealized gain (loss) on available for sale investment	(38)	(79)	(906)
Total other comprehensive (loss) income	(23,368)	(130,480)	(101,699)
Total comprehensive income (loss)	$ 44,062	$ (83,051)	$ 63,263

Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Jun. 30, 2014	$ 1,580,825	$ 1,031	$ 970,817	$ 589,001	$ (40,092)	$ 60,068
Beginning balance, shares at Jun. 30, 2014		103,143			2,906
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	164,962			164,962
Other comprehensive income (loss)	(101,699)					(101,699)
Issuance of common stock pursuant to compensation plans	26,085	$ 20	26,065
Issuance of common stock pursuant to compensation plans, shares		1,968
Issuance of common stock in connection with acquisitions	34,136	$ 7	34,129
Issuance of common stock in connection with acquisitions, shares		730
Stock based compensation income tax effects	29,219		29,219
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans	(18,058)				$ (18,058)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans, shares					323
Stock based compensation expense	12,197		12,197
Ending balance at Jun. 30, 2015	1,727,667	$ 1,058	1,072,427	753,963	$ (58,150)	(41,631)
Ending balance, shares at Jun. 30, 2015		105,841			3,229
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	47,429			47,429
Other comprehensive income (loss)	(130,480)					(130,480)
Issuance of common stock pursuant to compensation plans	4,400	$ 14	9,749		$ (5,363)
Issuance of common stock pursuant to compensation plans, shares		1,398			151
Issuance of common stock in connection with acquisitions	16,308	$ 3	16,305
Issuance of common stock in connection with acquisitions, shares		240
Stock based compensation income tax effects	12,037		12,037
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans	(25,535)				$ (25,535)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans, shares					638
Stock based compensation expense	12,688		12,688
Ending balance at Jun. 30, 2016	$ 1,664,514	$ 1,075	1,123,206	801,392	$ (89,048)	(172,111)
Ending balance, shares at Jun. 30, 2016	107,479	107,479			4,018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 67,430			67,430
Other comprehensive income (loss)	(23,368)					(23,368)
Issuance of common stock pursuant to compensation plans	1	$ 5	1,995		$ (1,999)
Issuance of common stock pursuant to compensation plans, shares		510			52
Stock based compensation income tax effects	2,865		2,865
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans	(8,268)				$ (8,268)
Shares withheld for payment of employee payroll taxes due on shares issued under stock based compensation plans, shares					217
Stock based compensation expense	9,658		9,658
Ending balance at Jun. 30, 2017	$ 1,712,832	$ 1,080	$ 1,137,724	$ 868,822	$ (99,315)	$ (195,479)
Ending balance, shares at Jun. 30, 2017	107,989	107,989			4,287

Consolidated Statement of Stockholders' Equity (Parenthetical)	12 Months Ended
	Jun. 30, 2014 $ / shares
Statement of Stockholders' Equity [Abstract]
Stock split ratio	2
Stock dividend, percent	100.00%
Common stock, par value (USD per share)	$ 0.01

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 67,430	$ 47,429	$ 164,962
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	68,697	65,622	57,380
Deferred income taxes	(10,456)	33,093	(2,667)
Equity in net loss (income) of equity-method investees	(129)	47	(628)
Stock based compensation	9,658	12,688	12,197
Contingent consideration expense	0	1,511	(253)
Gains on fire insurance recovery and other, net	0	(8,058)	0
Gains on pre-existing ownership interests in HPPC and Empire	0	0	(9,669)
Impairment charges	40,452	127,748	0
Other non-cash items, net	459	15,038	(1,434)
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of amounts applicable to acquisitions:
Accounts receivable	27,675	(12,886)	(19,582)
Inventories	(20,968)	(15,739)	(30,465)
Other current assets	32,637	(22,534)	(15,308)
Other assets and liabilities	(5,637)	3,281	(3,964)
Accounts payable and accrued expenses	6,806	(40,665)	34,913
Net cash provided by operating activities	216,624	206,575	185,482
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisitions of businesses, net of cash acquired	(19,544)	(157,061)	(104,633)
Purchases of property and equipment	(63,120)	(77,284)	(51,217)
Proceeds from sale of assets and other	6,419	0	4,550
Net cash used in investing activities	(76,245)	(234,345)	(151,300)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercises of stock options	0	0	18,643
Borrowings under bank revolving credit facility	90,000	323,904	92,000
Repayments under bank revolving credit facility	(181,203)	(145,053)	(43,049)
Repayments of senior notes	0	(150,000)	0
Repayments of other debt, net	(19,528)	(13,017)	(54,853)
Excess tax benefits from stock based compensation	3,298	11,317	25,701
Acquisition related contingent consideration	(2,498)	(1,547)	(3,217)
Shares withheld for payment of employee payroll taxes	(8,268)	(25,535)	(18,058)
Net cash (used in) provided by financing activities	(118,199)	69	17,167
Effect of exchange rate changes on cash	(3,114)	(11,295)	(8,178)
Net increase/(decrease) in cash and cash equivalents	19,066	(38,996)	43,171
Cash and cash equivalents at beginning of year	127,926	166,922	123,751
Cash and cash equivalents at end of year	$ 146,992	$ 127,926	$ 166,922

Description of Business and Basis of Presentation	12 Months Ended
Description of Business and Basis of Presentation	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION Description of Business The Hain Celestial Group, Inc., a Delaware corporation, and its subsidiaries (collectively, the “Company,” and herein referred to as “Hain Celestial,” “we,” “us,” and “our”) was founded in 1993 and is headquartered in Lake Success, New York. The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet — To Create and Inspire A Healthier Way of Life^TMand be the leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide. With a proven track record of strategic growth and profitability, the Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-for-you” products, providing consumers with the opportunity to lead A Healthier Way of Life^TM. Hain Celestial is a leader in many organic and natural products categories, with many recognized brands in the various market categories it serves, including Almond Dream^®, Arrowhead Mills^®, Bearitos^®, Better Bean^TM, BluePrint^®, Celestial Seasonings^®, Coconut Dream^®, Cully & Sully^®, Danival^®, DeBoles^®, Earth’s Best^®, Ella’s Kitchen^®, Empire^®, Europe’s Best^®, Farmhouse Fare^®, Frank Cooper’s^®, FreeBird^®, Gale’s^®, Garden of Eatin’^®, GG UniqueFiber^TM, Hain Pure Foods^®, Hartley’s^®, Health Valley^®, Imagine^®, Johnson’s Juice Co.^®, Joya^®, Kosher Valley^®, Lima^®, Linda McCartney’s^® (under license), MaraNatha^®, Natumi^®, New Covent Garden Soup Co.^®, Plainville Farms^®, Rice Dream^®, Robertson’s^®, Rudi’s Gluten-Free Bakery^®, Rudi’s Organic Bakery^®, Sensible Portions^®, Spectrum Organics^®, Soy Dream^®, Sun-Pat^®, SunSpire^®, Terra^®, The Greek Gods^®, Tilda^®, Walnut Acres^®, WestSoy^®, Yorkshire Provender^TM and Yves Veggie Cuisine^®. The Company’s personal care products are marketed under the Alba Botanica^®, Avalon Organics^®, Earth’s Best^®, JASON^®, Live Clean^® and Queen Helene^® brands. During fiscal year 2016, the Company commenced a strategic review, which it called “Project Terra,” that resulted in the Company redefining its core platforms, starting with the United States segment, for future growth based upon consumer trends to create and inspire A Healthier Way of Life™. In addition, beginning in fiscal year 2017, the Company launched Cultivate Ventures (“Cultivate”), a venture unit with a threefold purpose: (i) to strategically invest in the Company’s smaller brands in high potential categories such as BluePrint^® cold-pressed juices, SunSpire^® chocolates and DeBoles^® pasta by giving those products a dedicated, creative focus for refresh and relaunch; (ii) to incubate small acquisitions until they reach the scale for the Company’s core platforms; and (iii) to invest in concepts, products and technology that focus on health and wellness. Cultivate also includes Tilda^® and Yves Veggie Cuisine^®, which are global brands that have a growing presence in the United States. See Note 17, Segment Information, for information on the Company’s operating and reportable segments and the effect the formation of Cultivate had thereon. Basis of Presentation The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net income includes the Company’s equity in the current earnings or losses of such companies. Unless otherwise indicated, references in these consolidated financial statements to 2017, 2016 and 2015 or “fiscal” 2017, 2016 and 2015 or other years refer to our fiscal year ended June 30 of that respective year and references to 2018 or “fiscal” 2018 refer to our fiscal year ending June 30, 2018. Reclassifications Certain prior year amounts have been reclassified to conform with current year presentation. Use of Estimates The financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. These estimates include, among others, revenue recognition, trade promotions and sales incentives, valuation of accounts and chargeback receivables, accounting for acquisitions, valuation of long-lived assets, goodwill and intangible assets, stock-based compensation, and valuation allowances for deferred tax assets. We believe in the quality and reasonableness of our critical accounting estimates; however, materially different amounts may be reported under different conditions or using assumptions different from those that we have consistently applied.

Summary of Significant Accounting Policies and Practices

12 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies and Practices

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND PRACTICES

Cash and Cash Equivalents

The Company considers cash and cash equivalents to include cash in banks, commercial paper and deposits with financial institutions that can be liquidated without prior notice or penalty. The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

Revenue Recognition

Sales are recognized when the earnings process is complete, which occurs when the product is shipped in accordance with the terms of agreements, title and risk of loss transfers to the customer, collection is probable and pricing is fixed or determinable. Net sales includes shipping and handling charges billed to the customer and are reported net of discounts, trade promotions and sales incentives, consumer coupon programs and other costs, including estimated allowances for returns, allowances and discounts associated with aged or potentially unsalable product, and prompt pay discounts.

During the fourth quarter of fiscal 2016, the Company identified the practice of granting additional concessions to certain distributors in the United States and commenced an internal accounting review in order to (i) determine whether the revenue associated with those concessions was accounted for in the correct period and (ii) evaluate its internal control over financial reporting. The Audit Committee of the Company’s Board of Directors separately conducted an independent review of these matters and retained independent counsel to assist in their review. On November 16, 2016, the Company announced that the independent review of the Audit Committee was completed and that the review found no evidence of intentional wrongdoing in connection with the preparation of the Company’s financial statements.

Management’s accounting review included consideration of certain side agreements and concessions provided to distributors in the United States in fiscal 2015 and 2016, including payment terms beyond the customer’s standard terms, rights of return of product and post-sale concessions, most of which were associated with sales that occurred at the end of the quarter. It had been the Company’s policy to record revenue related to these distributors when title of the product transfers to the distributor. The Company concluded that its historical accounting policy for these distributors was appropriate as the sales price is fixed or determinable at the time ownership transfers to these distributors, based on the Company’s ability to make a reasonable estimate of future returns and certain concessions at the time of shipment.

Trade Promotions and Sales Incentives

Trade promotions and sales incentives include price discounts, slotting fees, in-store display incentives, cooperative advertising programs, new product introduction fees and coupons and are used to support sales of the Company’s products. These incentives are deducted from our net sales to determine reported net sales. The recognition of expense for these programs involves the use of judgment related to performance and redemption estimates. Differences between estimated expense and actual redemptions are normally insignificant and recognized as a change in estimate in the period such change occurs.

Trade Promotions. Accruals for trade promotions are recorded primarily at the time a product is sold to the customer based on expected levels of performance. Settlement of these liabilities typically occurs in subsequent periods primarily through an authorization process for deductions taken by a customer from amounts otherwise due to the Company.

Coupon Redemption. Coupon redemption costs are accrued in the period in which the coupons are offered, based on estimates of redemption rates that are developed by management. Management estimates are based on recommendations from independent coupon redemption clearing-houses as well as on historical information. Should actual redemption rates vary from amounts estimated, adjustments to accruals may be required.

Valuation of Accounts and Chargebacks Receivable and Concentration of Credit Risk

The Company routinely performs credit evaluations on existing and new customers. The Company applies reserves for delinquent or uncollectible trade receivables based on a specific identification methodology and also applies an additional reserve based on the experience the Company has with its trade receivables aging categories. Credit losses have been within the Company’s expectations in recent years. While one of the Company’s customers represented approximately 11% and 10% of trade receivables balances as of June 30, 2017 and 2016, the Company believes there is no significant or unusual credit exposure at this time.

Based on cash collection history and other statistical analysis, the Company estimates the amount of unauthorized deductions customers have taken that we expect will be collected and repaid in the near future and records a chargeback receivable. Differences between estimated collectible receivables and actual collections are recognized in earnings in the period such differences are determined.

During the fiscal years ended June 30, 2017, 2016 and 2015, sales to one customer and its affiliates approximated 10% of consolidated net sales. Sales to a second customer and its affiliates approximated 9%, 10% and 11% during the fiscal years ended June 30, 2017, 2016, and 2015, respectively.

In addition, cash and cash equivalents are maintained with several financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally these deposits may be redeemed upon demand.

Inventory

Inventory is valued at the lower of cost or market, utilizing the first-in, first-out method. The Company provides write-downs for finished goods expected to become non-saleable due to age and specifically identifies and provides for slow moving or obsolete raw ingredients and packaging.

Property, Plant and Equipment

Property, plant and equipment is carried at cost and depreciated or amortized on a straight-line basis over the estimated useful lives or lease term (for leasehold improvements), whichever is shorter. The Company believes the useful lives assigned to our property, plant and equipment are within ranges generally used in consumer products manufacturing and distribution businesses. The Company’s manufacturing plants and distribution centers, and their related assets, are reviewed when impairment indicators are present by analyzing underlying cash flow projections. The Company believes no impairment of the carrying value of such assets exists other than what is disclosed in Note 6, Property, Plant and Equipment, Net. Ordinary repairs and maintenance costs are expensed as incurred. The Company utilizes the following ranges of asset lives:



Buildings and improvements		10 - 40 years
Machinery and equipment		3 - 20 years
Furniture and fixtures		3 - 15 years

Leasehold improvements are amortized over the shorter of the respective initial lease term or the estimated useful life of the assets, and generally range from 3 to 15 years.

Goodwill and Other Indefinite-Lived Intangible Assets

Goodwill and other intangible assets with indefinite useful lives are not amortized but rather are tested at least annually for impairment, or when circumstances indicate that the carrying amount of the asset may not be recoverable. The Company performs its annual test for impairment at the beginning of the fourth quarter of its fiscal year.

Goodwill is tested for impairment at the reporting unit level. A reporting unit is an operating segment or a component of an operating segment. Goodwill is tested for impairment by either performing a qualitative evaluation or a two-step quantitative test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. We may elect not to perform the qualitative assessment for some or all reporting units and perform a two-step quantitative impairment test. The impairment test for goodwill requires the Company to compare the fair value of a reporting unit to its carrying value, including goodwill. The Company uses a blended analysis of a discounted cash flow model and a market valuation approach to determine the fair values of its reporting units. If the carrying value of a reporting unit exceeds its fair value, the Company would then compare the carrying value of the goodwill to its implied fair value in order to determine the amount of the impairment, if any.

Indefinite-lived intangible assets are tested for impairment by comparing the fair value of the asset to the carrying value. Fair value is determined based on a relief from royalty method that include significant management assumptions such as revenue growth rates, weighted average cost of capital, and assumed royalty rates. If the fair value is less than the carrying value, the asset is reduced to fair value.

See Note 7, Goodwill and Other Intangible Assets, for information on goodwill and intangibles impairment charges.

Cost of Sales

Included in cost of sales are the cost of products sold, including the costs of raw materials and labor and overhead required to produce the products, warehousing, distribution, supply chain costs, as well as costs associated with shipping and handling of our inventory.

Foreign Currency Translation and Remeasurement

The assets and liabilities of international operations are translated at the exchange rates in effect at the balance sheet date. Revenue and expense accounts are translated at the monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company's international operations are reported as a component of Accumulated other comprehensive loss in the Company’s consolidated balance sheets. Gains and losses arising from intercompany foreign currency transactions that are of a long-term nature are reported in the same manner as translation adjustments.

Gains and losses arising from intercompany foreign currency transactions that are not of a long-term nature and certain transactions of the Company’s subsidiaries which are denominated in currencies other than the subsidiaries’ functional currency are recognized as incurred in Other (income)/expense, net in the Consolidated Statements of Income.

Gain on Recovery of Insurance Proceeds

On October 25, 2014, a fire occurred at our Tilda rice milling facility in the United Kingdom. As a result, the Company recognized a gain of $9,752, representing the excess of the insurance proceeds over the net book value of fixed assets destroyed in the fire. As of June 30, 2016, the Company recorded a receivable of $4,234, representing the final settlement of the claim. The receivable is included in “Prepaid Expenses and Other Current Assets” on the Company’s Consolidated Balance Sheet, and the amount was collected in the first quarter of fiscal 2017. The milling facility was fully functional at the end of the third quarter of fiscal 2016.

Selling, General and Administrative Expenses

Included in selling, general and administrative expenses are advertising costs, promotion costs not paid directly to the Company’s customers, salary and related benefit costs of the Company’s employees in the finance, human resources, information technology, legal, sales and marketing functions, facility related costs of the Company’s administrative functions, research and development costs, and costs paid to consultants and third party providers for related services.

Research and Development Costs

Research and development costs are expensed as incurred and are included in selling, general and administrative expenses in the accompanying consolidated financial statements. Research and development costs amounted to $10,149 in fiscal 2017, $11,354 in fiscal 2016 and $10,271 in fiscal 2015, consisting primarily of personnel related costs. The Company’s research and development expenditures do not include the expenditures on such activities undertaken by co-packers and suppliers who develop numerous products on behalf of the Company and on their own initiative with the expectation that the Company will accept their new product ideas and market them under the Company’s brands.

Advertising Costs

Advertising costs, which are included in selling, general and administrative expenses, amounted to $33,053 in fiscal 2017, $26,968 in fiscal 2016 and $26,061 in fiscal 2015. Such costs are expensed as incurred.

Income Taxes

The Company follows the liability method of accounting for income taxes. Under the liability method, deferred taxes are determined based on the differences between the financial statement and tax bases of assets and liabilities at enacted rates in effect in the years in which the differences are expected to reverse. Valuation allowances are provided for deferred tax assets to the extent it is more likely than not that deferred tax assets will not be recoverable against future taxable income.

The Company recognizes liabilities for uncertain tax positions based on a two-step process prescribed by the authoritative guidance. The first step requires the Company to determine if the weight of available evidence indicates that the tax position has met the threshold for recognition; therefore, the Company must evaluate whether it is more likely than not that the position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step requires the Company to measure the tax benefit of the tax position taken, or expected to be taken, in an income tax return as the largest amount that is more than 50% likely of being realized upon ultimate settlement. The Company reevaluates the uncertain tax positions each period based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Depending on the jurisdiction, such a change in recognition or measurement may result in the recognition of a tax benefit or an additional charge to the tax provision in the period. The Company records interest and penalties in the provision for income taxes.

Fair Value of Financial Instruments

The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. At June 30, 2017 and 2016, the Company had $21,800 and $20,706, respectively, invested in money market funds, which are classified as cash equivalents. At June 30, 2017 and 2016, the carrying values of financial instruments such as accounts receivable, accounts payable, accrued expenses and other current liabilities, as well as borrowings under our credit facility and other borrowings, approximated fair value based upon either the short-term maturities or market interest rates of these instruments.

Derivative Instruments

The Company utilizes derivative instruments, principally foreign exchange forward contracts, to manage certain exposures to changes in foreign exchange rates. The Company’s contracts are hedges for transactions with notional balances and periods consistent with the related exposures and do not constitute investments independent of these exposures. These contracts, which are designated and documented as cash flow hedges, qualify for hedge accounting treatment in accordance with ASC 815, Derivatives and Hedging. Exposure to counterparty credit risk is considered low because these agreements have been entered into with high quality financial institutions.

All derivative instruments are recognized on the balance sheet at fair value. The effective portion of changes in the fair value of derivative instruments that qualify for hedge accounting treatment are recognized in stockholders’ equity as a component of Accumulated other comprehensive income (loss) until the hedged item is recognized in earnings. Changes in the fair value of derivatives that do not qualify for hedge accounting treatment, as well as the ineffective portion of any hedges, are recognized currently in earnings as a component of Other (Income)/Expense, net.

Stock-Based Compensation

The Company has employee and director stock-based compensation plans. The fair value of employee stock options is determined on the date of grant using the Black-Scholes option pricing model. The Company has used historical volatility in its estimate of expected volatility. The expected life represents the period of time (in years) for which the options granted are expected to be outstanding. The risk-free interest rate is based on the United States Treasury yield curve. The fair value of restricted stock awards is equal to the market value of the Company’s common stock on the date of grant or is estimated using a Monte Carlo simulation if the award contains a market condition.

The fair value of stock-based compensation awards is recognized as an expense over the vesting period using the straight-line method. For awards that contain a market condition, expense is recognized over the derived service period using a Monte Carlo simulation model. For restricted stock awards which include performance criteria, compensation expense is recorded when the achievement of the performance criteria is probable and is recognized over the performance and vesting service periods. Compensation expense is recognized for only that portion of stock based awards that are expected to vest. Therefore, estimated forfeiture rates that are derived from historical employee termination activity are applied to reduce the amount of compensation expense recognized. If the actual forfeitures differ from the estimate, additional adjustments to compensation expense may be required in future periods.

The Company receives an income tax deduction in certain tax jurisdictions for restricted stock grants when they vest and for stock options exercised by employees equal to the excess of the market value of our common stock on the date of exercise over the option price. Excess tax benefits (tax benefits resulting from tax deductions in excess of compensation cost recognized) are classified as a cash flow provided by financing activities in the accompanying Consolidated Statements of Cash Flows.

Valuation of Long-Lived Assets

The Company periodically evaluates the carrying value of long-lived assets, other than goodwill and intangible assets with indefinite lives, held and used in the business when events and circumstances occur indicating that the carrying amount of the asset may not be recoverable. An impairment test is performed when the estimated undiscounted cash flows associated with the asset or group of assets is less than their carrying value. Once such impairment test is performed, a loss is recognized based on the amount, if any, by which the carrying value exceeds the estimated fair value for assets to be held and used.

See Note 6, Property, Plant and Equipment, Net for information on long-lived asset impairment charges.

Net Income Per Share

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted net income per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock.

Recently Issued Accounting Pronouncements Not Yet Effective

In May 2017, the FASB (“Financial Accounting Standards Board”) issued Accounting Standards Update (“ASU”) 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting, which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The guidance is effective for annual periods beginning after December 15, 2017, with early adoption permitted, including adoption in any interim period for which financial statements have not yet been issued. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2017-09.

In February 2017, the FASB issued ASU 2017-05, Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets: Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets. The ASU was issued to clarify the scope of the previous standard and to add guidance for partial sales of nonfinancial assets. The ASU is effective for fiscal years and interim periods within those years beginning after December 15, 2017. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2017-05.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairments tests in fiscal years beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2017-04.

In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill and consolidation. The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within those periods, with early adoption permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2017-01.

In October 2016, the FASB issued ASU 2016-17, Consolidation (Topic 810): Interests Held through Related Parties that are Under Common Control. ASU 2016-17 changes how a reporting entity considers indirect interests held by related parties under common control when evaluating whether it is the primary beneficiary of a variable interest entity (“VIE”). ASU 2016-17 is effective on a retrospective basis for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2016, with early adoption permitted. The adoption of the provisions of ASU 2016-17 is not expected to have a material impact on the Company’s consolidated financial position or results of operations.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. Currently, U.S. GAAP prohibits recognizing current and deferred income tax consequences for an intra-entity asset transfer until the asset has been sold to an outside party. ASU 2016-16 states that an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The new standard is effective for public companies in fiscal years beginning after December 15, 2017. Early adoption is permitted. The amendments should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption.

The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-16.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (A Consensus of the Emerging Issues Task Force). ASU 2016-15 provides guidance on the classification of certain cash receipts and payments in the statement of cash flows. The guidance must be applied retrospectively to all periods presented but may be applied prospectively if retrospective application would be impracticable. The new standard is effective for public companies in fiscal years beginning after December 15, 2017. Early adoption is permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-15.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses, which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for years beginning after December 15, 2019, and interim periods therein. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-13.

In March 2016, the FASB issued ASU 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which simplifies several aspects of the accounting for share-based payments, including immediate recognition of all excess tax benefits and deficiencies in the income statement, changing the threshold to qualify for equity classification up to the employees’ maximum statutory tax rates, allowing an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures as they occur and clarifying the classification on the statement of cash flows for the excess tax benefit and employee taxes paid when an employer withholds shares for tax-withholding purposes. The standard will be effective for the first interim period within annual periods beginning after December 15, 2016, with early adoption permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-09.

In March 2016, the FASB issued ASU 2016-07, Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting. ASU 2016-07 eliminates the requirement that an entity retroactively adopt the equity method of accounting if an investment qualifies for use of the equity method as a result of an increase in the level of ownership or degree of influence. The equity method investor is required to add the cost of acquiring the additional interest in the investee to the current basis of the investor’s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. ASU 2016-07 is effective for annual reporting periods beginning after December 15, 2016, and interim periods within those annual periods. The adoption of the provisions of ASU 2016-07 is not expected to have a material impact on the Company’s consolidated financial position or results of operations.

In March 2016, the FASB issued ASU 2016-05, Derivatives and Hedging (Topic 815): Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships. Under ASU 2016-05, the novation of a derivative contract (i.e., a change in the counterparty) in a hedge accounting relationship does not, in and of itself, require dedesignation of that hedge accounting relationship. The hedge accounting relationship could continue uninterrupted if all of the other hedge accounting criteria are met, including the expectation that the hedge will be highly effective when the creditworthiness of the new counterparty to the derivative contract is considered. The guidance is effective for fiscal years beginning after December 15, 2016, and interim periods therein. Early adoption is permitted. Entities may apply the guidance prospectively or on a modified retrospective basis. The adoption of the provisions of ASU 2016-05 is not expected to have a material impact on the Company’s consolidated financial position or results of operations.

In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 revises accounting for operating leases by a lessee, among other changes, and requires a lessee to recognize a liability to make lease payments and an asset representing its right to use the underlying asset for the lease term in the balance sheet. The standard is effective for the first interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-02.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. ASU 2016-01 requires that most equity investments be measured at fair value, with subsequent changes in fair value recognized in net income. The pronouncement also impacts financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. ASU 2016-01 is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those annual periods. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-01.

In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. ASU 2015-11 requires inventory measured using any method other than last-in, first out or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market. ASU 2015-11 is effective for annual reporting periods beginning after December 15, 2016 and for interim periods within such annual period. Early application is permitted. The Company is currently evaluating the potential effects of adopting the provisions of ASU 2015-11.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Under ASU 2014-09, an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. Subsequent to the issuance of ASU 2014-09, the FASB has issued various additional ASUs clarifying and amending this new revenue guidance. These ASUs apply to all companies that enter into contracts with customers to transfer goods or services and are effective for public entities for interim and annual reporting periods beginning after December 15, 2017. Early adoption is permitted. Entities have the choice to apply these ASUs either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying these standards at the date of initial application and not adjusting comparative information. The Company is currently evaluating the provisions of ASU No. 2014-09 and assessing the impact on its financial statements. As part of our assessment work-to-date, we have formed an implementation work team, begun training on the new ASU’s revenue recognition model and are beginning to review our customer contracts. We are also evaluating the impact of the new standard on certain common practices currently employed by the Company and by other manufacturers of consumer products, such as slotting fees, co-operative advertising, rebates and other pricing allowances, merchandising funds and consumer coupons. We have not yet determined if the full retrospective or modified retrospective method will be applied.

Earnings Per Share

12 Months Ended

Jun. 30, 2017

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:



	Fiscal Year Ended June 30,
	2017		2016		2015
Numerator:
Net income	$	67,430	$	47,429	$	164,962

Denominator:
Basic weighted average shares outstanding	103,611		103,135		101,703
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units	637		1,048		1,718
Diluted weighted average shares outstanding	104,248		104,183		103,421

Net income per common share:
Basic	$	0.65	$	0.46	$	1.62
Diluted	$	0.65	$	0.46	$	1.60

Basic earnings per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted share units. Diluted earnings per share includes the dilutive effects of common stock equivalents such as stock options and unvested restricted stock awards. The Company used income from continuing operations as the control number in determining whether potential common shares were dilutive or anti-dilutive. The same number of potential common shares used in computing the diluted per share amount from continuing operations was also used in computing the diluted per share amounts from discontinued operations even if those amounts were anti-dilutive.

There were 271, 282 and 107 stock based awards excluded from our diluted earnings per share calculations for the fiscal years ended June 30, 2017, 2016 and 2015, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods. Additionally, 12 restricted stock awards were excluded from our diluted earnings per share calculation for the fiscal year ended June 30, 2017, as such awards were antidilutive. There were no antidilutive awards excluded from our diluted earnings per share calculations for the fiscal years ended June 30, 2016 and 2015.

Share Repurchase Program

On June 21, 2017, the Company's Board of Directors authorized the repurchase of up to $250,000 of the Company’s issued and

outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations, including the Company’s historical strategy of pursuing accretive acquisitions. The Company did not repurchase any shares under this program in fiscal 2017, and accordingly, as of the end of fiscal 2017, we had $250,000 of remaining capacity under our share repurchase program.

Acquisitions

12 Months Ended

Jun. 30, 2017

Business Combinations [Abstract]

Acquisitions

ACQUISITIONS

The Company accounts for acquisitions in accordance with ASC 805, Business Combinations. The results of operations of the acquisitions have been included in the consolidated results from their respective dates of acquisition. The purchase price of each acquisition is allocated to the tangible assets, liabilities and identifiable intangible assets acquired based on their estimated fair values. Acquisitions may include contingent consideration, the fair value of which is estimated on the acquisition date as the present value of the expected contingent payments, determined using weighted probabilities of possible payments. The fair values assigned to identifiable intangible assets acquired were determined primarily by using an income approach which was based on assumptions and estimates made by management. Significant assumptions utilized in the income approach were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by authoritative guidance. The excess of the purchase price over the fair value of the identified assets and liabilities has been recorded as goodwill.

The costs related to all acquisitions have been expensed as incurred and are included in “Acquisition related expenses, restructuring and integration charges” in the Consolidated Statements of Income. Acquisition-related costs of $2,035, $3,724 and $5,731 were expensed in the fiscal years ended June 30, 2017, 2016 and 2015, respectively. The expenses incurred primarily related to professional fees and other transaction related costs associated with our recent acquisitions.

Fiscal 2017

On June 19, 2017, the Company acquired Sonmundo, Inc. d/b/a The Better Bean Company (“Better Bean”), which offers prepared beans and bean-based dips sold in refrigerated tubs under the Better Bean^TM brand. Consideration for the transaction consisted of cash, net of cash acquired, totaling $3,434. Additionally, contingent consideration of up to a maximum of $4,000 is payable based on the achievement of specified operating results over the three year period following the closing date. Better Bean is included in our Cultivate operating segment, which is part of Rest of World. Net sales and income before income taxes attributable to the Better Bean acquisition and included in our consolidated results were less than 1% of consolidated results.

On April 28, 2017, the Company acquired The Yorkshire Provender Limited (“Yorkshire Provender”), a producer of premium branded soups based in North Yorkshire in the United Kingdom. Yorkshire Provender supplies leading retailers, on-the-go food outlets and food service providers in the United Kingdom. Consideration for the transaction consisted of cash, net of cash acquired, totaling £12,465 (approximately $16,110 at the transaction date exchange rate). Additionally, contingent consideration of up to a maximum of £1,500 is payable based on the achievement of specified operating results at the end of the three year period following the closing date. Yorkshire Provender is included in our United Kingdom operating and reportable segment. Net sales and income before income taxes attributable to Yorkshire Provender and included in our consolidated results were less than 1% of consolidated results.

The fair values assigned to identifiable intangible assets acquired were based on assumptions and estimates made by management. Identifiable intangible assets acquired consisted of customer relationships valued at $7,045 with a weighted average estimated useful life of 14 years and trade names valued at $3,673 with indefinite lives. The acquisition resulted in goodwill, which represents the future economic benefits expected to arise that could not be individually identified and separately recognized, including use of the Company’s existing infrastructure to expand sales of the acquired business’ products and to expand sales of the Company’s existing products into new regions. The goodwill recorded as a result of these acquisitions is not expected to be deductible for tax purposes.

Fiscal 2016

On December 21, 2015, the Company acquired Orchard House Foods Limited (“Orchard House”), a leader in pre-cut fresh fruit, juices, fruit desserts and ingredients with facilities in Corby and Gateshead in the United Kingdom. Orchard House supplies leading retailers, on-the-go food outlets, food service providers and manufacturers in the United Kingdom. Consideration for the transaction consisted of cash, net of cash acquired, totaling £76,923 (approximately $114,113 at the transaction date exchange rate). The acquisition was funded with borrowings under the Credit Agreement (as defined in Note 9, Debt and Borrowings). Additionally, contingent consideration of up to £3,000 was potentially payable to the sellers based on the outcome of a review by the Competition and Markets Authority (“CMA”) in the United Kingdom. As a result of this review, the Company agreed to divest certain portions of its own-label juice business in the fourth quarter of fiscal 2016. On September 15, 2016, the contingent consideration obligation referenced above was settled in the amount of £1,500. Orchard House is included in the United Kingdom operating and reportable segment. Net sales and income before income taxes attributable to the Orchard House acquisition and included in our consolidated results were $88,580 and $4,622, respectively, for the fiscal year ended June 30, 2016.

On July 24, 2015, the Company acquired Formatio Beratungs- und Beteiligungs GmbH and its subsidiaries (“Mona”), a leader in plant-based foods and beverages with facilities in Germany and Austria. Mona offers a wide range of organic and natural products under the Joya^® and Happy^® brands, including soy, oat, rice and nut based drinks as well as plant-based yogurts, desserts, creamers, tofu and private label products, sold to leading retailers in Europe, primarily in Austria and Germany and eastern European countries. Consideration for the transaction consisted of cash, net of cash acquired, totaling €22,753 (approximately $24,948 at the transaction date exchange rate) and 240 shares of the Company’s common stock valued at $16,308. Also included in the acquisition was the assumption of net debt totaling €16,252. The cash portion of the purchase price was funded with borrowings under our Credit Agreement. Mona is included in the Europe operating segment which is part of Rest of World. Net sales and income before income taxes attributable to the Mona acquisition and included in our consolidated results were $58,767 and $3,464, respectively, for the fiscal year ended June 30, 2016.

The fair values assigned to identifiable intangible assets acquired were based on assumptions and estimates made by management. Identifiable intangible assets acquired consisted of customer relationships valued at $58,726 with a weighted average estimated useful life of 15 years and trade names valued at $10,965 with indefinite lives. The acquisition resulted in goodwill, which represents the future economic benefits expected to arise that could not be individually identified and separately recognized, including use of the Company’s existing infrastructure to expand sales of the acquired business’ products and to expand sales of the Company’s existing products into new regions. The goodwill recorded as a result of these acquisitions is not expected to be deductible for tax purposes.

The following table provides unaudited pro forma results of continuing operations for the fiscal years ended June 30, 2016 and 2015, as if the acquisitions of Orchard House, Mona, Hain Pure Protein Corporation (“HPPC”), Belvedere International, Inc. (“Belvedere”), and EK Holdings, Inc. (“Empire”) had been completed at the beginning of fiscal 2015 (see below for acquisitions that occurred in fiscal 2015). The information has been provided for illustrative purposes only and does not purport to be indicative of the actual results that would have been achieved by the Company for the periods presented or that will be achieved by the combined company in the future. The pro forma information has been adjusted to give effect to items that are directly attributable to the transactions and are expected to have a continuing impact on the combined results.



	Fiscal Year Ended June 30,
	2016		2015
Net sales from continuing operations	$	2,973,872	$	2,947,536
Net income from continuing operations	$	51,270	$	177,435
Net income per common share from continuing operations - diluted	$	0.49	$	1.71

Fiscal 2015

On July 17, 2014, the Company acquired the remaining 51.3% of HPPC that it did not already own, at which point HPPC became a wholly-owned subsidiary. HPPC processes, markets and distributes antibiotic-free, organic and other poultry products. HPPC held a 19% interest in Empire, which grows, processes and sells kosher poultry and other products. Consideration in the transaction consisted of cash totaling $20,310, net of cash acquired, and 463 shares of the Company’s common stock valued at $19,690. The cash consideration paid was funded with then-existing cash balances. Additionally, HPPC’s existing bank borrowings were repaid on September 30, 2014 with proceeds from borrowings under the Credit Agreement . The carrying amount of the pre-existing 48.7% investment in HPPC as of June 30, 2014 was $29,327. Due to the acquisition of the remaining 51.3% of HPPC, the Company adjusted the carrying amount of its pre-existing investment to its fair value. This resulted in a gain of $6,747 recorded in “Gain on sale of business” in the Consolidated Statements of Income. HPPC is its own operating segment which is part of the Hain Pure Protein reportable segment. Net sales and income before income taxes attributable to the HPPC acquisition and included in our consolidated results were $290,593 and $26,649 respectively, for the fiscal year ended June 30, 2015.

On February 20, 2015, the Company acquired Belvedere, a leader in health and beauty care products including the Live Clean^® brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada. Consideration in the transaction consisted of cash totaling C$17,454 ($13,988 at the transaction date exchange rate), net of cash acquired, which included debt that was repaid at closing, and was funded with then-existing cash balances. Additionally, contingent consideration of up to a maximum of C$4,000 was payable based on the achievement of specified operating results during the two consecutive one-year periods following the closing date. In both the fourth quarter of fiscal 2017 and 2016, the Company paid C$2,000 in settlement of the Belvedere contingent consideration obligation. Belvedere is included in our Canada operating segment, which is part of Rest of World. Net sales and income before income taxes attributable to the Belvedere acquisition and included in our consolidated results were less than 1% of consolidated results.

On March 4, 2015, the Company acquired the remaining 81% of Empire that it did not already own, at which point Empire became a wholly-owned subsidiary. Consideration in the transaction consisted of cash totaling $57,595, net of cash acquired, which included debt that was repaid at closing. The acquisition was funded with borrowings under the Credit Agreement. The carrying amount of the pre-existing 19% investment in Empire as of March 4, 2015 was $6,864. Due to the acquisition of the remaining 81% of Empire, the Company adjusted the carrying amount of its pre-existing investment to its fair value. This resulted in a gain of $2,922 recorded in “Gain on sale of business” in the Consolidated Statements of Income. Empire is its own operating segment which is part of the Hain Pure Protein reportable segment. Net sales and income before income taxes attributable to the Empire acquisition and included in our consolidated results were $46,604 and $4,752 respectively, for the fiscal year ended June 30, 2015.

The fair values assigned to identifiable intangible assets acquired were based on assumptions and estimates made by management. Identifiable intangible assets acquired consisted of customer relationships valued at $15,903 with a weighted average estimated useful life of 11 years, a patent valued at $1,700 with an estimated life of 9 years, and trade names valued at $43,747 with indefinite lives. The acquisition resulted in goodwill, which represents the future economic benefits expected to arise that could not be individually identified and separately recognized, including use of the Company’s existing infrastructure to expand sales of the acquired business’ products. The goodwill recorded as a result of these acquisitions is not expected to be deductible for tax purposes.

The following table provides unaudited pro forma results of continuing operations for the fiscal years ended June 30, 2015, as if the acquisitions completed in fiscal 2015 (HPPC, Belvedere and Empire) had been completed at the beginning of fiscal year 2015. The information has been provided for illustrative purposes only and does not purport to be indicative of the actual results that would have been achieved by the Company for the periods presented or that will be achieved by the combined company in the future. The pro forma information has been adjusted to give effect to items that are directly attributable to the transactions and are expected to have a continuing impact on the combined results, which include amortization expense associated with acquired identifiable intangible assets and the impact of reversing our previously recorded equity in HPPC’s net income as prior to the date of acquisition, HPPC was accounted for under the equity-method of accounting.



	Fiscal Year Ended June 30, 2015
Net sales from continuing operations	$	2,718,466
Net income from continuing operations	$	168,196
Net income per common share from continuing operations - diluted	$	1.63

Inventories

12 Months Ended

Jun. 30, 2017

Inventory, Net [Abstract]

Inventories

INVENTORIES

Inventories consisted of the following:



	June 30, 2017		June 30, 2016
Finished goods	$	264,148	$	238,184
Raw materials, work-in-progress and packaging	163,160		170,380
	$	427,308	$	408,564

Property, Plant And Equipment, Net

12 Months Ended

Jun. 30, 2017

Property, Plant and Equipment [Abstract]

Property, Plant And Equipment, Net

PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consisted of the following:



	June 30, 2017		June 30, 2016
Land	$	33,930	$	35,825
Buildings and improvements	116,723		102,086
Machinery and equipment	350,689		358,362
Computer hardware and software	51,486		48,829
Furniture and fixtures	15,993		14,165
Leasehold improvements	29,296		28,471
Construction in progress	16,119		14,495
	614,236		602,233
Less: Accumulated depreciation and amortization	243,725		212,392
	$	370,511	$	389,841

Depreciation and amortization expense for the fiscal years ended June 30, 2017, 2016, and 2015 was $40,824, $38,124 and $32,293, respectively.

In the fourth quarter of fiscal 2017, the Company determined that it was more likely than not that certain fixed assets at one of its manufacturing facilities in the United Kingdom would be sold or otherwise disposed of before the end of their estimated useful lives due to the Company’s decision to exit its own-label chilled desserts business over the next twelve months. As such, the Company recorded a $23,712 non-cash impairment charge related to the long-lived assets associated with the own-label chilled desserts business to their estimated fair values, which was equal to its salvage value. Additionally, the Company recorded a $2,661 non-cash impairment charge related to fixed assets in the United States.

In fiscal 2016, the Company recorded a $3,476 non-cash impairment charge related to long-lived assets associated with the divestiture of certain portions of its own-label juice business in connection with its acquisition of Orchard House in the United Kingdom and $1,004 in fiscal 2015 related to leasehold improvements due to the relocation of our New York based BluePrint manufacturing facility.

Goodwill And Other Intangible Assets

12 Months Ended

Jun. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill And Other Intangible Assets

GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table shows the changes in the carrying amount of goodwill by business segment:



	United States			United Kingdom			Hain Pure Protein		Rest of World			Total
Balance as of June 30, 2015 (a):	$	610,745		$	420,721		$	41,970	$	62,242		$	1,135,678
Acquisitions	—			57,019			(881)		20,674			76,812
Impairment charge	—			(84,548		)	—		—			(84,548		)
Translation and other adjustments, net	(5,043		)	(60,631		)	—		(1,932		)	(67,606		)
Balance as of June 30, 2016 (b):	605,702			332,561			41,089		80,984			1,060,336
Acquisitions	3,083			6,962			—		—			10,045
Reallocation of goodwill between reporting units	(16,377		)	—			—		16,377			—
Translation and other adjustments, net	(992		)	(10,388		)	—		980			(10,400		)
Balance as of June 30, 2017 (b):	$	591,416		$	329,135		$	41,089	$	98,341		$	1,059,981

(a) The total carrying value of goodwill is reflected net of $42,029 of accumulated impairment charges, of which $12,810 related to the Company’s United Kingdom operating segment and $29,219 related to the Company’s Europe operating segment.

(b) The total carrying value of goodwill is reflected net of $126,577 of accumulated impairment charges, of which $97,358 related to the Company’s United Kingdom operating segment and $29,219 related to the Company’s Europe operating segment.

The Company completed its annual goodwill impairment analysis in the fourth quarter of fiscal 2017, in conjunction with its budgeting and forecasting process for fiscal year 2018, and concluded that no indicators of impairment existed at any of its reporting units except for its Hain Daniels reporting unit, which is included in the United Kingdom segment. Based on the step one analysis performed, the Company concluded that the fair value of the Hain Daniels reporting unit was below its carrying value, indicating that the second step of the impairment test was necessary. Under the second step, the carrying value of the Hain Daniels reporting unit’s goodwill was compared to the implied fair value of that goodwill. The implied fair value of goodwill was determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit’s goodwill. As a result of the allocation, less value was attributed to the other identifiable tangible and intangible assets, and the residual fair value of goodwill exceeded its carrying value by 20%. Accordingly, no goodwill impairment was recognized.

As indicators of impairment existed within the Hain Daniels reporting unit, the Company performed an assessment of the recoverability for other long-lived assets, such as property, plant and equipment and finite-lived intangibles assets, namely customer relationships. The Company performed an assessment of the recoverability in accordance with the general valuation requirements set forth under ASC Topic 360 - Accounting for the Impairment of Long-Lived Assets. The result of this assessment indicated that no impairment existed for these assets.

For the fiscal year ended June 30, 2016, the Company recognized a goodwill impairment charge of $82,614 in its Hain Daniels reporting unit primarily as a result of lowered projected long-term revenue growth rates and profitability levels resulting from increased competition, changes in market trends and the mix of products sold. Additionally, a goodwill impairment charge of $1,934 was recognized during the fiscal year ended June 30, 2016 related to the divestiture of certain portions of the Company’s own-label juice business in connection with the Orchard House acquisition, which was sold in the first quarter of fiscal 2017. See Note 4, Acquisitions, for details.

Additions during the fiscal year ended June 30, 2017 were due to the acquisitions of Better Bean and Yorkshire Provender on June 19, 2017 and April 28, 2017, respectively. The additions during fiscal year ended June 30, 2016 were due to the acquisitions of Orchard House and Mona on December 21, 2015 and July 24, 2015, respectively.

Other Intangible Assets

The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and intangible assets not subject to amortization:



	June 30, 2017			June 30, 2016
Non-amortized intangible assets:
Trademarks and tradenames (a)	$	424,817		$	441,140
Amortized intangible assets:
Other intangibles	247,712			245,040
Less: accumulated amortization	(99,261		)	(81,393		)
Net carrying amount	$	573,268		$	604,787

(a) The gross carrying value of trademarks and tradenames is reflected net of $60,202 and $46,123 of accumulated impairment charges for the fiscal years ended June 30, 2017 and 2016, respectively.

Indefinite-lived intangible assets, which are not amortized, consist primarily of acquired trade names and trademarks. Indefinite-lived intangible assets are evaluated on an annual basis in conjunction with the Company’s evaluation of goodwill. In assessing fair value, the Company utilizes a “relief from royalty” methodology. This approach involves two steps: (i) estimating the royalty rates for each trademark and (ii) applying these royalty rates to a projected net sales stream and discounting the resulting cash flows to determine fair value. If the carrying value of the indefinite-lived intangible assets exceeds the fair value of the asset, the carrying value is written down to fair value in the period identified. The result of this assessment for the year ended June 30, 2017 indicated that the fair value of certain of the Company’s tradenames was below their carrying value, and therefore an impairment charge of $14,079 ($7,579 in the United Kingdom segment and $6,500 in the United States segment) was recognized during the fiscal year ended June 30, 2017. During the fiscal year ended June 30, 2016, an impairment charge of $39,724 ($20,932 in the United Kingdom segment and $18,792 in the United States segment) related to certain of the Company’s tradenames was recognized. There were no impairment charges recorded in fiscal 2015 related to indefinite-lived intangible assets.

Amortizable intangible assets, which are deemed to have a finite life, primarily consist of customer relationships and are being amortized over their estimated useful lives of 3 to 25 years. Amortization expense included in continuing operations was as follows:



	Fiscal Year ended June 30,
	2017		2016		2015
Amortization of intangible assets	$	18,402	$	18,869	$	17,846

Expected amortization expense over the next five fiscal years is as follows:



	Fiscal Year ending June 30,
	2018		2019		2020		2021		2022
Estimated amortization expense	$	18,385	$	16,129	$	14,748	$	14,306	$	14,210

The weighted average remaining amortization period of amortized intangible assets is 10.3 years.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Accrued Expenses and Other Current Liabilities

12 Months Ended

Jun. 30, 2017

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:



	June 30, 2017		June 30, 2016
Payroll, employee benefits and other administrative accruals	$	70,740	$	43,774
Freight and warehousing accruals	20,294		16,007
Selling and marketing related accruals	9,785		9,826
Other accruals	7,695		9,196
	$	108,514	$	78,803

Debt and Borrowings

12 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Debt and Borrowings

DEBT AND BORROWINGS

Debt and borrowings consisted of the following:



	June 30, 2017		June 30, 2016
Credit Agreement borrowings payable to banks	$	733,715	$	827,860
Tilda short-term borrowing arrangements	7,761		19,121
Other borrowings	8,672		15,703
	750,148		862,684
Short-term borrowings and current portion of long-term debt	9,844		26,513
Long-term debt, less current portion	$	740,304	$	836,171

Credit Agreement

On December 12, 2014, the Company entered into the Second Amended and Restated Credit Agreement (the “Credit Agreement”) which provides for a $1,000,000 unsecured revolving credit facility which may be increased by an additional uncommitted $350,000, provided certain conditions are met. The Credit Agreement expires in December 2019. Borrowings under the Credit Agreement may be used to provide working capital, finance capital expenditures and permitted acquisitions, refinance certain existing indebtedness and for other lawful corporate purposes. The Credit Agreement provides for multicurrency borrowings in Euros, Pounds Sterling and Canadian Dollars as well as other currencies which may be designated. In addition, certain wholly-owned foreign subsidiaries of the Company may be designated as co-borrowers. The Credit Agreement contains restrictive covenants usual and customary for facilities of its type, which include, with specified exceptions, limitations on the Company’s ability to engage in certain business activities, incur debt, have liens, make capital expenditures, pay dividends or make other distributions, enter into affiliate transactions, consolidate, merge or acquire or dispose of assets, and make certain investments, acquisitions and loans. The Credit Agreement also requires the Company to satisfy certain financial covenants, such as maintaining a consolidated interest coverage ratio (as defined in the Credit Agreement) of no less than 4.0 to 1.0 and a consolidated leverage ratio (as defined in the Credit Agreement) of no more than 3.5 to 1.0. The consolidated leverage ratio is subject to a step-up to 4.0 to 1.0 for the four full fiscal quarters following an acquisition. Obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company. As of June 30, 2017, there were $733,715 of borrowings and $6,180 of letters of credit outstanding under the Credit Agreement and $260,105 available, and the Company was in compliance with all associated covenants.

The Credit Agreement provides that loans will bear interest at rates based on (a) the Eurocurrency Rate, as defined in the Credit Agreement, plus a rate ranging from 0.875% to 1.70% per annum; or (b) the Base Rate, as defined in the Credit Agreement, plus a rate ranging from 0.00% to 0.70% per annum, the relevant rate being the Applicable Rate. The Applicable Rate will be determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. Swing line loans and Global Swing Line loans denominated in United States dollars will bear interest at the Base Rate plus the Applicable Rate and Global Swing Line loans denominated in foreign currencies shall bear interest based on the overnight Eurocurrency Rate for loans denominated in such currency plus the Applicable Rate. The weighted average interest rate on outstanding borrowings under the Credit Agreement at June 30, 2017 was 2.93%. Additionally, the Credit Agreement contains a Commitment Fee, as defined in the Credit Agreement, on the amount unused under the Credit Agreement ranging from 0.20% to 0.30% per annum. Such Commitment Fee is determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement.

Tilda Short-Term Borrowing Arrangements

Tilda maintains short-term borrowing arrangements primarily used to fund the purchase of rice from India and other countries. The maximum borrowings permitted under all such arrangements are £52,000. Outstanding borrowings are collateralized by the current assets of Tilda, typically have six-month terms and bear interest at variable rates typically based on LIBOR plus a margin (weighted average interest rate of approximately 2.7% at June 30, 2017).

Other Borrowings

Other borrowings primarily relate to a cash pool facility in Europe. The cash pool facility provides our Europe operating segment with sufficient liquidity to support the Company’s growth objectives within this segment. The maximum borrowings permitted under the cash pool arrangement are €12,500. Outstanding borrowings bear interest at variable rates typically based on EURIBOR plus a margin of 1.1% (weighted average interest rate of approximately 1.1% at June 30, 2017).

Maturities of all debt instruments at June 30, 2017, are as follows:



Due in Fiscal Year	Amount
2018	$	9,844
2019	1,829
2020	735,865
2021	1,891
2022	426
Thereafter	293
	$	750,148

Interest paid during the fiscal years ended June 30, 2017, 2016 and 2015 amounted to $18,873, $24,288 and $22,865, respectively.

Income Taxes

12 Months Ended

Jun. 30, 2017

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

The components of income (loss) before income taxes and equity in earnings of equity-method investees were as follows:



	Fiscal Year Ended June 30,
	2017		2016			2015
Domestic	$	49,046	$	158,025		$	170,884
Foreign	40,097		(39,617		)	41,985
Total	$	89,143	$	118,408		$	212,869

The provision (benefit) for income taxes consisted of the following:



	Fiscal Year Ended June 30,
	2017			2016			2015
Current:
Federal	$	14,448		$	21,304		$	32,910
State and local	2,966			1,798			8,311
Foreign	14,884			14,737			9,981
	32,298			37,839			51,202
Deferred:
Federal	(3,199		)	30,711			(912		)
State and local	961			5,017			(1,069		)
Foreign	(8,218		)	(2,635		)	(686		)
	(10,456		)	33,093			(2,667		)
Total	$	21,842		$	70,932		$	48,535

For the fiscal year ended June 30, 2017, the Company received net cash income tax refunds of $2,900. Cash paid for income taxes, net of refunds, during the fiscal years ended June 30, 2016 and 2015 amounted to $44,225 and $47,317, respectively.

The reconciliation of the U.S. federal statutory rate to our effective rate on income before provision for income taxes was as follows:



	Fiscal Year Ended June 30,
	2017			%			2016				%		2015			%
Expected United States federal income tax at statutory rate	$	31,200		35.0	%		$	41,443			35.0	%	$	74,504		35.0	%
State income taxes, net of federal benefit	3,034			3.4	%		5,447				4.6	%	4,795			2.2	%
Domestic manufacturing deduction	(1,691		)	(1.9	)%		(1,233		)		(1.0	)%	(1,210		)	(0.6	)%
Foreign income at different rates	(6,539		)	(7.3	)%		(4,051		)		(3.4	)%	(9,515		)	(4.5	)%
Impairment of goodwill and intangibles	—			—	%	—	23,172			—	19.6	%	—			—	%
Change in valuation allowance	(60		)	(0.1	)%		5,067				4.3	%	963			0.5	%
Corporate tax reorganization	—			—	%		(4,173		)		(3.5	)%	(20,670		)	(9.7	)%
Unrealized foreign exchange losses	807			0.9	%		7,056				6.0	%	—			—	%
Change in reserves for uncertain tax positions	(4,417		)	(5.0	)%		1,448				1.2	%	(635		)	(0.3	)%
Non-taxable gains on acquisition of pre-existing ownership interests in HPPC and Empire	—			—	%		—				—	%	(2,793		)	(1.3	)%
Reduction of deferred tax liabilities resulting from change in United Kingdom tax rate	(1,841		)	(2.1	)%		(4,942		)		(4.2	)%	—			—	%
Other	1,349			1.6	%		1,698				1.3	%	3,096			1.5	%
Provision for income taxes	$	21,842		24.5	%		$	70,932			59.9	%	$	48,535		22.8	%

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Deferred tax assets and liabilities consisted of the following:



	June 30, 2017			June 30, 2016
Noncurrent deferred tax assets/(liabilities):
Basis difference on inventory	$	10,933		$	11,232
Reserves not currently deductible	23,757			17,652
Basis difference on intangible assets	(145,558		)	(145,673		)
Basis difference on property and equipment	(20,137		)	(25,933		)
Other comprehensive income	(768		)	(4,623		)
Net operating loss and tax credit carryforwards	22,197			25,340
Stock based compensation	3,996			4,632
Other	(616		)	1,176
Valuation allowances	(14,850		)	(15,310		)
Noncurrent deferred tax liabilities, net	(121,046		)	(131,507		)

Total net deferred tax liabilities	$	(121,046	)	$	(131,507	)


(1)	The June 30, 2017 balance sheet includes $429 of non-current deferred tax assets in Other Assets.

At June 30, 2017 and 2016, the Company had U.S. federal net operating loss (“NOL”) carryforwards of approximately $33,177 and $38,433, respectively, the majority of which will not expire until 2033. Certain of these federal loss carryforwards are subject to Internal Revenue Code Section 382 which imposes limitations on utilization following certain changes in ownership of the entity generating the loss carryforward. We had foreign NOL carryforwards of approximately $43,306 and $42,573 in the same respective years, the majority of which are indefinite lived.

At June 30, 2017 and 2016, the Company had U.S. federal foreign tax credit carryforwards of approximately $877. These credit carryforwards have various expiration dates through 2020.

As of June 30, 2017, the Company has not provided for deferred taxes on the excess of financial reporting over the tax basis of investments in certain foreign subsidiaries in the amount of $156,405 as the Company plans to reinvest such earnings indefinitely outside the United States. If these earnings were repatriated in the future, additional income and withholding tax expense would be incurred. Due to complexities in the laws of the U.S. and foreign jurisdictions and the assumptions that would have to be made, it is not practicable to estimate the total amount of income taxes that would have to be provided on such earnings.

As required by the authoritative guidance on accounting for income taxes, the Company evaluates the realizability of deferred tax assets on a jurisdictional basis at each reporting date. Accounting for income taxes requires that a valuation allowance be established when it is more likely than not that all or a portion of the deferred tax assets will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred tax assets are not more likely than not realizable, we establish a valuation allowance. We have recorded valuation allowances in the amounts of $14,850 and $15,310 at June 30, 2017 and 2016, respectively.

The changes in valuation allowances against deferred income tax assets were as follows:



	Fiscal Year Ended June 30,
	2017			2016
Balance at beginning of year	$	15,310		$	10,926
Additions charged to income tax expense	1,862			7,484
Reductions credited to income tax expense	(1,922		)	(2,417		)
Currency translation adjustments	(400		)	(683		)
Balance at end of year	$	14,850		$	15,310

Unrecognized tax benefits activity, including interest and penalties, is summarized below:



	Fiscal Year Ended June 30,
	2017			2016			2015
Balance at beginning of year	$	16,019		$	10,759		$	11,058
Additions based on tax positions related to the current year	217			4,276			1,089
Additions based on tax positions related to prior years	—			1,404			202
Reductions due to lapse in statute of limitations and settlements	(4,634		)	(420		)	(1,590		)
Balance at end of year	$	11,602		$	16,019		$	10,759

As of June 30, 2017, the Company had $11,602 of unrecognized tax benefits, of which $6,409 represents the amount that, if recognized, would impact the effective tax rate in future periods. As of June 30, 2016 and 2015, the Company had $16,019 and $10,759, respectively, of unrecognized tax benefits of which $10,826 and $9,375, respectively, would impact the effective income tax rate in future periods. Accrued liabilities for interest and penalties were $460 and $650 at June 30, 2017 and 2016, respectively. Interest and penalties (expense and/or benefit) are recorded as a component of the provision (benefit) for income taxes in the consolidated financial statements. The Company believes that it is reasonably possible that its unrecognized tax benefits could decrease by $3,754 by June 30, 2018 due to settlements and expirations of statutes of limitations, all of which would reduce the income tax provision for continuing operations.

The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and several foreign jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years prior to fiscal 2014. However, to the extent we generated NOLs or tax credits in closed tax years, future use of the NOL or tax credit carry forward balance would be subject to examination within the relevant statute of limitations for the year in which utilized. The Company is no longer subject to tax examinations in the United Kingdom for years prior to fiscal 2014. Given the uncertainty regarding when tax authorities will complete their examinations and the possible outcomes of their examinations, a current estimate of the range of reasonably possible significant increases or decreases of income tax that may occur within the next twelve months cannot be made. Although there are various tax audits currently ongoing, the Company does not believe the ultimate outcome of such audits will have a material impact on the Company’s consolidated financial statements.

Stockholders' Equity

12 Months Ended

Jun. 30, 2017

Equity [Abstract]

Stockholders' Equity

STOCKHOLDERS’ EQUITY

Preferred Stock

The Company is authorized to issue “blank check” preferred stock of up to 5,000 shares with such designations, rights and preferences as may be determined from time to time by the Board of Directors. Accordingly, the Board of Directors is empowered to issue, without stockholder approval, preferred stock with dividends, liquidation, conversion, voting or other rights which could decrease the amount of earnings and assets available for distribution to holders of the Company’s Common Stock. At June 30, 2017 and 2016, no preferred stock was issued or outstanding.

Common Stock Issued

See Note 4, Acquisitions, for details surrounding issuance of the Company’s common stock in connection with recent acquisitions.

Accumulated Other Comprehensive Loss

The following tables present the changes in accumulated other comprehensive loss:



	Fiscal Year Ended June 30,
	2017			2016
Foreign currency translation adjustments:
Other comprehensive loss before reclassifications ⁽¹⁾	$	(22,951	)	$	(129,874	)
Deferred gains/(losses) on cash flow hedging instruments:
Other comprehensive income before reclassifications	196			4,666
Amounts reclassified into income ⁽²⁾	(575		)	(5,193		)
Unrealized gain on available for sale investment:
Other comprehensive loss before reclassifications	(51		)	(79		)
Amounts reclassified into income ⁽³⁾	13			—
Net change in accumulated other comprehensive loss	$	(23,368	)	$	(130,480	)


(1)	Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature of $18,385 and $107,221 for the fiscal years ended June 30, 2017 and 2016, respectively.


(2)	Amounts reclassified into income for deferred gains on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were $1,233 and $6,788 for the fiscal years ended June 30, 2017 and 2016, respectively.

(3)

Amounts reclassified into income for gains on sale of available for sale investments were based on the average cost of the shares held (See Note 13, Investments and Joint Ventures). Such amounts are recorded in “Other (income)/expense, net” in the Consolidated Statements of Income and was $21 before taxes for the fiscal year ended June 30, 2017. There were no amounts reclassified into income for the fiscal year ended June 30, 2016.

Stock Based Compensation And Incentive Performance Plans

12 Months Ended

Jun. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Based Compensation And Incentive Performance Plans

STOCK BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

The Company has two shareholder-approved plans, the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan and the 2000 Directors Stock Plan, under which the Company’s officers, senior management, other key employees, consultants and directors may be granted options to purchase the Company’s common stock or other forms of equity-based awards.

2002 Long-Term Incentive and Stock Award Plan, as amended

In November 2002, our stockholders approved the 2002 Long-Term Incentive and Stock Award Plan. An aggregate of 3,200 shares of common stock were originally reserved for issuance under this plan. At various Annual Meetings of Stockholders, including the 2014 Annual Meeting, the plan was amended to increase the number of shares issuable to 31,500 shares. The plan provides for the granting of stock options, stock appreciation rights, restricted stock, restricted share units, performance shares, performance share units and other equity awards to employees, directors and consultants. Awards denominated in shares of common stock other than options and stock appreciation rights will be counted against the available share limit as two and seven hundredths shares for every one share covered by such award. All of the options granted to date under the plan have been incentive or non-qualified stock options providing for the exercise price equal to the fair market price at the date of grant. Stock option awards granted under the plan expire seven years after the date of grant. Options and other stock-based awards vest in accordance with provisions set forth in the applicable award agreements. No awards shall be granted under this plan after November 20, 2024.

There were no options granted under this plan in fiscal years 2017, 2016 or 2015.

There were 195, 498 and 440 shares of restricted stock and restricted share units granted under this plan during fiscal years 2017, 2016 and 2015, respectively. Included in these grants during fiscal years 2016 and 2015 were 366 and 365, respectively, of restricted stock and restricted share units granted under the Company’s long-term incentive programs, of which 284 and 109, respectively, are subject to the achievement of minimum performance goals established under those programs (see “Long-term Incentive Plan,” in this Note 12) or market conditions.

At June 30, 2017, 988 unvested restricted stock and restricted share units were outstanding under this plan, and there were 11,523 shares available for grant under this plan. At June 30, 2017, there were no options outstanding under this plan.

2000 Directors Stock Plan, as amended

In May 2000, our stockholders approved the 2000 Directors Stock Plan. The plan originally provided for the granting of stock options to non-employee directors to purchase up to an aggregate of 1,500 shares of our common stock. In December 2003, the plan was amended to increase the number of shares issuable to 1,900 shares. In March 2009, the plan was amended to permit the granting of restricted stock, restricted share units and dividend equivalents and was renamed. All of the options granted to date under this plan have been non-qualified stock options providing for the exercise price equal to the fair market price at the date of grant. Stock option awards granted under the plan expire seven years after the date of grant. No awards shall be granted under this plan after December 1, 2015.

There were no options granted under this plan in fiscal years 2017, 2016, or 2015.

There were no shares of restricted stock granted under this plan during fiscal years 2017 and 2016. During fiscal year 2015, 20 shares of restricted stock were granted under this plan. At June 30, 2017, 4 unvested restricted shares were outstanding, and there will be no further restricted shares or options granted under this plan.

Other Plans

At June 30, 2017, there were 122 options outstanding that were granted under the prior Celestial Seasonings plan.

Although no further awards can be granted under the 2000 Directors Stock Plan, as amended, or the prior Celestial Seasonings plan, the options and restricted stock outstanding continue in accordance with the terms of the respective plans and grants.

There were 12,643 shares of common stock reserved for future issuance in connection with stock-based awards as of June 30, 2017.

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Income for stock based compensation plans were as follows:



	Fiscal Year Ended June 30,
	2017		2016		2015
Compensation cost (included in selling, general and administrative expense)	$	9,658	$	12,688	$	12,197
Related income tax benefit	$	3,622	$	4,758	$	4,695

Stock Options

A summary of the stock option activity for the three fiscal years ended June 30 is as follows:



	2017		Weighted Average Exercise Price		2016		Weighted Average Exercise Price		2015		Weighted Average Exercise Price
Outstanding at beginning of year	342		$	6.66	1,249		$	6.12	2,674		$	9.83
Exercised	(220	)	$	9.10	(907	)	$	5.91	(1,425	)	$	13.08
Outstanding at end of year	122		$	2.26	342		$	6.66	1,249		$	6.12

Options exercisable at end of year	122		$	2.26	342		$	6.66	1,249		$	6.12



	Fiscal Year Ended June 30,
	2017		2016		2015
Intrinsic value of options exercised	$	6,507	$	27,147	$	62,213
Cash received from stock option exercises	$	—	$	—	$	18,643
Tax benefit recognized from stock option exercises	$	2,538	$	10,587	$	24,213

For options outstanding and exercisable at June 30, 2017, the aggregate intrinsic value (the difference between the closing stock price on the last day of trading in the year and the exercise price) was $4,458, and the weighted average remaining contractual life was 14.0 years. At June 30, 2017, there was no unrecognized compensation expense related to stock option awards.

Restricted Stock

Awards of restricted stock may be either grants of restricted stock or restricted share units that are issued at no cost to the recipient. For restricted stock grants, at the date of grant the recipient has all rights of a stockholder, subject to certain restrictions on transferability and a risk of forfeiture. For restricted share units, legal ownership of the shares is not transferred to the employee until the unit vests. Restricted stock and restricted share unit grants vest in accordance with provisions set forth in the applicable award agreements, which may include performance criteria for certain grants. The compensation cost of these awards is determined using the fair market value of the Company’s common stock on the date of the grant. Compensation expense for restricted stock awards with a service condition is recognized on a straight-line basis over the vesting term. Compensation expense for restricted stock awards with a performance condition is recorded when the achievement of the performance criteria is probable and is recognized over the performance and vesting service periods.

A summary of the restricted stock and restricted share units activity for the three fiscal years ended June 30 is as follows:



	2017		Weighted Average Grant Date Fair Value (per share)	2016		Weighted Average Grant Date Fair Value (per share)	2015		Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock and restricted share units - beginning of year	1,121		$28.24	1,145		$32.30	1,259		$25.44
Granted	195		$33.68	416		$24.54	311		$54.11
Vested	(290	)	$33.89	(408	)	$35.13	(402	)	$26.86
Forfeited	(34	)	$29.88	(32	)	$45.83	(23	)	$40.65
Non-vested restricted stock and restricted share units - end of year	992		$27.59	1,121		$28.24	1,145		$32.30



	Fiscal Year Ended June 30,
	2017		2016		2015
Fair value of restricted stock and restricted share units granted	$	6,567	$	10,203	$	16,462
Fair value of shares vested	$	9,866	$	18,917	$	21,481
Tax benefit recognized from restricted shares vesting	$	3,768	$	7,139	$	8,364

On July 3, 2012, the Company entered into a Restricted Stock Agreement (the “Agreement”) with Irwin D. Simon, the Company’s Chairman, President and Chief Executive Officer. The Agreement provides for a grant of 800 shares of restricted stock (the “Shares”), the vesting of which is both market and time-based. The market condition is satisfied in increments of 200 Shares upon the Company’s common stock achieving four share price targets. On the last day of any forty-five consecutive trading day period during which the average closing price of the Company’s common stock on the Nasdaq Global Select Market equals or exceeds the following prices: $31.25, $36.25, $41.25 and $50.00, respectively, the market condition for each increment of 200 Shares will be satisfied. The market conditions were required to be satisfied prior to June 30, 2017. Once each market condition has been satisfied, a tranche of 200 Shares will vest in equal amounts annually over a five-year period. Except in the case of a change of control, termination without cause, death or disability (each as defined in Mr. Simon’s Employment Agreement), the unvested Shares are subject to forfeiture unless Mr. Simon remains employed through the applicable market and time vesting periods. The grant date fair value for each tranche was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment and the time frame most likely for goal attainment. The total grant date fair value of the Shares was estimated to be $16,151, which was expected to be recognized over a weighted-average period of approximately 4.0 years. On September 28, 2012, August 27, 2013, December 13, 2013 and October 22, 2014, the four respective market conditions were satisfied. As such, the four tranches of 200 Shares each are expected to vest in equal amounts over the five-year period commencing on the first anniversary of the date the market condition for the respective tranche was satisfied.

At June 30, 2017, $12,117 of unrecognized stock-based compensation expense, net of estimated forfeitures, related to non-vested restricted stock awards, inclusive of the Shares, was expected to be recognized over a weighted-average period of approximately 1.9 years.

Long-Term Incentive Plan

The Company maintains a long-term incentive program (the “LTI Plan”). The LTI Plan currently consists of a two-year performance-based long-term incentive plan (the “2015-2016 LTIP”) and a three-year performance-based long-term incentive plan (the “2016-2018 LTIP”) that provide for a combination of equity grants and performance awards that can be earned over the respective performance period. Participants in the LTI Plans include the Company’s executive officers, including the Chief Executive Officer, and certain other key executives.

The Compensation Committee administers the LTI Plans and is responsible for, among other items, establishing the target values of awards to participants and selecting the specific performance factors for such awards. The Compensation Committee determines the specific payout to the participants. Such awards may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee, provided that any such stock-based awards shall be issued pursuant to and be subject to the terms and conditions of the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan, as in effect and as amended from time to time.

Upon the adoption of the 2015-2016 LTIP, the Compensation Committee granted an initial award to each participant in the form of equity-based instruments (restricted stock or restricted share units), for a portion of the individual target awards (the “Initial Equity Grants”). These Initial Equity Grants are subject to time vesting requirements, and a portion are also subject to the achievement of minimum performance goals. The 2015-2016 LTIP awards contain an additional year of time-based vesting. The Initial Equity Grants are expensed over the respective vesting periods on a straight-line basis. The payment of the actual awards earned at the end of the applicable performance period, if any, will be reduced by the value of the Initial Equity Grants.

Upon adoption of the 2016-2018 LTIP, the Compensation Committee granted performance units to each participant, the achievement of which is dependent upon a defined calculation of relative total shareholder return over the period from July 1, 2015 to June 30, 2018 (the “TSR Grant”). The grant date fair value for these awards was separately estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment. Each performance unit translates into one unit of common stock. The TSR grant represents half of each participant’s target award. The other half of the 2016-2018 LTIP is based on the Company’s achievement of specified net sales growth targets over this three-year period and, if achieved, may be paid in cash and/or unrestricted shares of the Company’s common stock at the discretion of the Compensation Committee.

In October 2015, although the target values previously set under the LTI Plan covering 2014 and 2015 fiscal years (the “2014-2015 LTIP”) were fully achieved, the Compensation Committee exercised its discretion to reduce the awards due to the challenges faced by the Company in connection with the nut butter voluntary recall during fiscal year 2015. After deducting the value of the Initial Equity Grants, the reduced awards to participants related to the 2014-2015 LTIP totaled $4,400 (which were settled by the issuance of 82 unrestricted shares of the Company’s common stock in October 2015).

The Company has recorded expense (in addition to the stock based compensation expense associated with the Initial Equity Grants and the TSR Grant) of $4,044 and $4,967, for the fiscal years ended June 30, 2017 and 2015, respectively, related to the LTI plans. In the fiscal year ended June 30, 2016, the Company recorded a reversal of expense of $2,037 related to the LTI plans.

Investments And Joint Ventures	12 Months Ended
Investments And Joint Ventures	Jun. 30, 2017
Equity Method Investments and Joint Ventures [Abstract]
Investments And Joint Ventures	INVESTMENTS AND JOINT VENTURES Equity method investments In October 2009, the Company formed a joint venture, Hutchison Hain Organic Holdings Limited (“HHO”), with Hutchison China Meditech Ltd. (“Chi-Med”), a majority-owned subsidiary of CK Hutchison Holdings Limited, to market and distribute certain of the Company’s brands in Hong Kong, China and other surrounding markets. Voting control of the joint venture is shared equally between the Company and Chi-Med, although, in the event of a deadlock, Chi-Med has the ability to cast the deciding vote, and therefore, the investment is being accounted for under the equity method of accounting. At June 30, 2017 and June 30, 2016, the carrying value of the Company’s 50.0% investment in and advances to HHO were $1,629 and $1,729, respectively, and are included in the Consolidated Balance Sheet as a component of “Investments and joint ventures.” On October 27, 2015, the Company acquired a 14.9% interest in Chop’t Creative Salad Company LLC (“Chop’t”). Chop’t develops and operates fast-casual, fresh salad restaurants in the Northeast and Mid-Atlantic United States. Chop’t markets and sells certain of the Company’s branded products and provides consumer insight and feedback. The investment is being accounted for as an equity method investment due to the Company’s representation on the Board of Directors. At June 30, 2017 and June 30, 2016, the carrying value of the Company’s investment in Chop’t was $16,487 and $17,448, respectively, and is included in the Consolidated Balance Sheet as a component of “Investments and joint ventures.” The Company’s current ownership percentage may be diluted in the future to 11.9%, pending the distribution of additional ownership interests. Available-For-Sale Securities The Company has a less than 1% equity ownership interest in Yeo Hiap Seng Limited (“YHS”), a Singapore-based natural food and beverage company listed on the Singapore Exchange, which is accounted for as an available-for-sale security. The Company sold 102 of its YHS shares during the fiscal year ended June 30, 2017, which resulted in a pre-tax loss of $21 on the sales, and is recognized as a component of “Other (income)/expense, net.” No shares were sold during the fiscal year ended June 30, 2016. The remaining shares held at June 30, 2017 totaled 933. The fair value of these shares held was $882 (cost basis of $1,164) at June 30, 2017 and $1,067 (cost basis of $1,291) at June 30, 2016 and is included in “Investments and joint ventures,” with the related unrealized gain or loss, net of tax, included in “Accumulated other comprehensive loss” in the Consolidated Balance Sheet. The company concluded that the decline in its YHS investment below its cost basis is temporary and, accordingly, has not recognized a loss in the Consolidated Statements of Operations. In making this determination, the company considered its intent and ability to hold the investment until the cost is recovered, the financial condition and near-term prospects of YHS, the magnitude of the loss compared to the investment’s cost, and publicly available information about the industry and geographic region in which YHS operates.

Financial Instruments Measured At Fair Value

12 Months Ended

Jun. 30, 2017

Fair Value Disclosures [Abstract]

Financial Instruments Measured At Fair Value

FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:


•	Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;


•	Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and


•	Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2017:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	21,800	$	21,800	$	—	$	—
Forward foreign currency contracts	99		—		99		—
Available for sale securities	882		882		—		—
	$	22,781	$	22,682	$	99	$	—
Liabilities:
Forward foreign currency contracts	$	53	$	—	$	53	$	—
Contingent consideration, noncurrent	2,656		—		—		2,656
Total	$	2,709	$	—	$	53	$	2,656

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2016:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	20,706	$	20,706	$	—	$	—
Forward foreign currency contracts	531		—		531		—
Available for sale securities	1,067		1,067		—		—
	$	22,304	$	21,773	$	531	$	—
Liabilities:
Contingent consideration, current	3,553		—		—		3,553
Total	$	3,553	$	—	$	—	$	3,553

Available for sale securities consist of the Company’s investment in YHS (see Note 13, Investments and Joint Ventures). Fair value is measured using the market approach based on quoted prices. The Company utilizes the income approach to measure fair value for its foreign currency forward contracts. The income approach uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices.

The Company estimates the original fair value of the contingent consideration as the present value of the expected contingent payments, determined using the weighted probabilities of the possible payments. The Company reassesses the fair value of contingent payments on a periodic basis. Although the Company believes its estimates and assumptions are reasonable, different assumptions, including those regarding the operating results of the respective businesses, or changes in the future may result in different estimated amounts.

In connection with the acquisition of Belvedere in February 2015, payment of a portion of the respective purchase price was contingent upon the achievement of certain operating results. Contingent consideration of up to a maximum of C$4,000 related to the Belvedere acquisition was payable based on the achievement of specified operating results during the two consecutive one-year periods following the closing date. In both the fourth quarter of fiscal 2017 and 2016, the Company paid C$2,000 in each quarter in settlement of the Belvedere contingent consideration obligation.

In connection with the acquisition of Orchard House during fiscal 2016, contingent consideration of up to £3,000 was potentially payable to the sellers based on the outcome of a review by the CMA in the United Kingdom. As a result of this review, the Company agreed to divest certain portions of its own-label juice business in the fourth quarter of fiscal 2016, and on September 15, 2016, the Company settled the contingent consideration related to this acquisition for £1,500.

In connection with the acquisitions of Better Bean and Yorkshire Provender during fiscal 2017, payments of a portion of the respective purchase prices were contingent upon the achievement of certain operating results. Contingent consideration of up to a maximum of $4,000 related to the Better Bean acquisition is payable based on the achievement of specified operating results over the three years following the closing date. Contingent consideration of up to a maximum of £1,500 related to the Yorkshire Provender acquisition is payable based on the achievement of specified operating results at the end of the three year period following the closing date.

The following table summarizes the Level 3 activity:



	Fiscal Year ended June 30,
	2017			2016
Balance at beginning of year	$	3,553		$	1,636
Fair value of initial contingent consideration	2,652			2,225
Contingent consideration adjustments	526			1,511
Contingent consideration paid	(3,969		)	(1,547		)
Translation adjustment	(106		)	(272		)
Balance at end of year	$	2,656		$	3,553

The change in fair value of contingent consideration is included in acquisition related expenses, restructuring and integration charges in the Company’s Consolidated Statement of Income.

There were no transfers of financial instruments between the three levels of fair value hierarchy during the fiscal years ended June 30, 2017 or 2016.

The carrying amount of cash and cash equivalents, accounts receivable, net, accounts payable and certain accrued expenses and other current liabilities approximate fair value due to the short-term maturities of these financial instruments. The Company’s debt approximates fair value due to the debt bearing fluctuating market interest rates (See Note 9, Debt and Borrowings).

Derivative Instruments

The Company primarily has exposure to changes in foreign currency exchange rates relating to certain anticipated cash flows and firm commitments from its international operations. To reduce that risk, the Company may enter into certain derivative financial instruments, when available on a cost-effective basis, to manage such risk. Certain derivative instruments are designated at inception as hedges and measured for effectiveness both at inception and on an ongoing basis. Derivative instruments not designated as hedges are marked-to-market each reporting period with any unrealized gains or losses recognized in earnings. Derivative financial instruments are not used for speculative purposes.

The Company utilizes foreign currency contracts to hedge forecasted transactions, including intercompany transactions, on certain foreign currencies and designates these derivative instruments as foreign currency cash flow hedges when appropriate. The notional and fair value amounts of the Company’s cash flow hedges at June 30, 2017 were $1,828 and $84 of net assets, respectively. There were $6,000 of notional amount and $531 of net assets of cash flow hedges at June 30, 2016. The fair value of these derivatives is included in prepaid expenses and other current assets and accrued expenses and other current liabilities in the Consolidated Balance Sheet. For these derivatives, which qualify as hedges of probable forecasted cash flows, the effective portion of changes in fair value is temporarily reported in accumulated other comprehensive income and recognized in earnings when the hedged item affects earnings. These foreign exchange contracts have maturities over the next two months.

The Company assesses effectiveness at the inception of the hedge and on a quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective in offsetting changes in the cash flows of hedged items. Any ineffective portion of change in fair value is not deferred in accumulated other comprehensive income and is included in current period results. The Company will discontinue cash flow hedge accounting when the forecasted transaction is no longer probable of occurring on the originally forecasted date or when the hedge is no longer effective. There were no discontinued foreign exchange hedges for the fiscal years ended June 30, 2017 and 2016.

There were $6,114 of notional amount and $38 of net liabilities of derivatives not designated as hedges as of June 30, 2017.

Gains and losses related to both designated and non-designated foreign currency exchange contracts are recorded in the Company's consolidated statements of operations based upon the nature of the underlying hedged transaction and were not material in the fiscal years ended June 30, 2017 and 2016.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Commitments And Contingencies

12 Months Ended

Jun. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments And Contingencies

COMMITMENTS AND CONTINGENCIES

Lease commitments and rent expense

The Company leases office, manufacturing and warehouse space. These leases provide for additional payments of real estate taxes and other operating expenses over a base period amount.

The aggregate minimum future lease payments for these operating leases at June 30, 2017 are as follows:



Fiscal Year
2018	$	18,771
2019	14,831
2020	12,615
2021	9,401
2022	8,516
Thereafter	37,702
	$	101,836

Rent expense charged to operations for the fiscal years ended June 30, 2017, 2016 and 2015 was $34,028, $33,803 and $29,560, respectively.

Off Balance Sheet Arrangements

At June 30, 2017, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K that have had, or are likely to have, a material current or future effect on our consolidated financial statements.

Legal Proceedings

Securities Class Actions Filed in Federal Court

On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) Flora v. The Hain Celestial Group, Inc., et al., (the “Flora Complaint”); (2) Lynn v. The Hain Celestial Group, Inc., et al. (the “Lynn Complaint”); and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints, the “Securities Complaints”). On June 5, 2017, the court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”), and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. On June 21, 2017, the Company received notice that plaintiff Spadola voluntarily dismissed his claims without prejudice to his ability to participate in the Consolidated Securities Action as an absent class member. On August 4, 2017, Co-Lead Plaintiffs in the Consolidated Securities Action filed an amended complaint on behalf of a purported class consisting of all persons who purchased or otherwise acquired Hain Celestial securities between November 5, 2013 and February 10, 2017 (the “Amended Complaint”). The Amended Complaint names as defendants the Company and certain of its current and former officers (collectively, the “Defendants”) and asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. On August 9, 2017, the Court approved the Defendants’ proposed briefing schedule and ordered that the Defendants move to dismiss the Amended Complaint by October 3, 2017.

Stockholder Derivative Complaints Filed in State Court

On September 16, 2016, a stockholder derivative complaint, Paperny v. Heyer, et al. (the “Paperny Complaint”), was filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers of the Company alleging breach of fiduciary duty, unjust enrichment, lack of oversight and corporate waste. On December 2, 2016 and December 29, 2016, two additional stockholder derivative complaints were filed in New York State Supreme Court in Nassau County against the Board of Directors and certain officers under the captions Scarola v. Simon (the “Scarola Complaint”) and Shakir v. Simon (the “Shakir Complaint” and, together with the Paperny Complaint and the Scarola Complaint, the “Derivative Complaints”), respectively. Both the Scarola Complaint and the Shakir Complaint allege breach of fiduciary duty, lack of oversight and unjust enrichment. On February 16, 2017, the parties for the Derivative Complaints entered into a stipulation consolidating the matters under the caption In re The Hain Celestial Group (the “Consolidated Derivative Action”) in New York State Supreme Court in Nassau County, ordering the Shakir Complaint as the operative complaint, and the parties agreed to stay the Consolidated Derivative Action until November 2, 2017.

Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court

On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District of New York against the Board of Directors and certain officers of the Company under the captions Silva v. Simon, et al. (the “Silva Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment.

On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the Board of Directors and certain officers of the Company. The complaint alleges that the Company’s directors and certain officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results. The complaint also alleges that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. On August 9, 2017, the Court granted an order to unseal this case and reveal Gary Merenstein as the plaintiff.

On August 10, 2017, the court granted the parties stipulation to consolidate the Barnes Compliant, the Silva Complaint and the Merenstein Compliant under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the “Consolidated Stockholder Class and Derivative Action”) and to appoint Robbins Arroyo LLP and Scott+Scott as Co-Lead Counsel, with the Law Offices of Thomas G. Amon as Liaison Counsel for Plaintiffs. The parties agreed that the defendants in the Stockholder Class and Derivative Action shall have 60 days to answer or otherwise move to dismiss after the plaintiffs file a consolidated complaint with the court or designate an already filed complaint as the operative complaint.

SEC Investigation

As previously disclosed, the Company voluntarily contacted the SEC in August 2016 to advise it of the Company’s delay in the filing of its periodic reports and the performance of the independent review conducted by the Audit Committee. The Company has continued to provide information to the SEC on an ongoing basis, including, among other things, the results of the independent review of the Audit Committee as well as other information pertaining to its internal accounting review relating to revenue recognition. On January 31, 2017, the SEC issued a subpoena to the Company seeking documents relevant to its investigation. The Company is in the process of responding to the SEC’s requests for information and intends to cooperate fully with the SEC.

Other

In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company believes the probable final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial position, cash flows or liquidity.

Defined Contribution Plans	12 Months Ended
Defined Contribution Plans	Jun. 30, 2017
Retirement Benefits [Abstract]
Defined Contribution Plans	DEFINED CONTRIBUTION PLANS We have a 401(k) Employee Retirement Plan (the “Plan”) to provide retirement benefits for eligible employees. All full-time employees of the Company and its wholly-owned domestic subsidiaries are eligible to participate upon completion of 30 days of service. On an annual basis, we may, in our sole discretion, make certain matching contributions. For the fiscal years ended June 30, 2017, 2016 and 2015, we made contributions to the Plan of $1,367, $1,236 and $1,090, respectively. In addition, certain of our international subsidiaries maintain separate defined contribution plans for their employees, however the amounts are not significant to the consolidated financial statements.

Segment Information

12 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION

Prior to July 1, 2016, the Company’s operations were managed in seven operating segments: the United States, United Kingdom,

Tilda, Hain Pure Protein Corporation (“HPPC”), EK Holdings, Inc. (“Empire”), Canada and Europe. The United States operating segment was also a reportable segment. The United Kingdom and Tilda operating segments were reported in the aggregate as “United Kingdom”, while HPPC and Empire were reported in the aggregate as “Hain Pure Protein,” and Canada and Europe were combined and reported as “Rest of World.”

Effective July 1, 2016, due to changes to the Company’s internal management and reporting structure resulting from the formation of Cultivate, certain brands previously included within the United States operating segment were moved to a new operating segment called Cultivate. As a result, the Company is now managed in eight operating segments: the United States (excluding Cultivate), United Kingdom, Tilda, HPPC, Empire, Canada, Europe and Cultivate. The United States, excluding Cultivate, is its own reportable segment. Cultivate is now combined with Canada and Europe and reported within Rest of World. There were no changes to the United Kingdom and Hain Pure Protein reportable segments. The prior period segment information contained below has been adjusted to reflect the Company’s new operating and reporting structure. See Note 1, Description of Business and Basis of Presentation, for additional details surrounding the formation of Cultivate.

Net sales and operating income are the primary measures used by the Company’s Chief Operating Decision Maker (“CODM”) to evaluate segment operating performance and to decide how to allocate resources to segments. The CODM is the Company’s Chief Executive Officer. Expenses related to certain centralized administration functions that are not specifically related to an operating segment are included in “Corporate and Other.” Corporate and Other expenses are comprised mainly of the compensation and related expenses of certain of the Company’s senior executive officers and other selected employees who perform duties related to the entire enterprise, as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a whole. Additionally, acquisition related expenses, restructuring and integration charges, impairment charges, and accounting review costs are included in “Corporate and Other.” Expenses that are managed centrally but can be attributed to a segment, such as employee benefits and certain facility costs, are allocated based on reasonable allocation methods. Assets are reviewed by the CODM on a consolidated basis and therefore are not reported by operating segment.

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.



	Fiscal Years ended June 30,
	2017			2016			2015
Net Sales: ⁽¹⁾
United States	$	1,191,262		$	1,249,123		$	1,253,156
United Kingdom	768,301			774,877			722,830
Hain Pure Protein	509,606			492,510			337,197
Rest of World	383,942			368,864			296,430
	$	2,853,111		$	2,885,374		$	2,609,613

Operating Income:
United States	$	157,506		$	203,481		$	180,937
United Kingdom	39,749			56,000			44,985
Hain Pure Protein	1,382			31,558			28,685
Rest of World	32,010			27,898			22,327
	230,647			318,937			276,934
Corporate and Other ⁽²⁾	(119,842		)	(168,577		)	(43,072		)
	$	110,805		$	150,360		$	233,862

(1)

One of our customers accounted for approximately 10% of our consolidated net sales for the fiscal years ended June 30, 2017, 2016 and 2015, respectively, which were primarily related to the United States and United Kingdom segments. A second customer accounted for approximately, 9%, 10% and 11% of our consolidated net sales for the fiscal years ended June 30, 2017, 2016 and 2015, respectively, which were primarily related to the United States segment.

(2)

Corporate and Other includes $10,388, $12,065 and $7,244 of acquisition related expenses, restructuring and integration charges for the fiscal years ended June 30, 2017, 2016 and 2015, respectively. Corporate and Other also includes an impairment charge of $14,079 ($7,579 related to the United Kingdom segment and $6,500 related to the United States segment) related to certain of the Company’s tradenames, a $26,373 impairment charge primarily related to long-lived assets associated with the exit of certain portions of our own-label chilled desserts business in the United Kingdom segment and $29,562 of accounting review costs for the fiscal year ended June 30, 2017. Additionally, Corporate and Other includes goodwill impairment charges of $84,548 for the fiscal year ended June 30, 2016 related to the United Kingdom segment, an impairment charge of $39,724 ($20,932 related to the United Kingdom segment and $18,792 related to the United States segment) related to certain of the Company’s tradenames and a $3,476 impairment charge related to long-lived assets associated with the divestiture of certain portions of our own-label juice business in the United Kingdom. Lastly, Corporate and Other includes a long-lived asset impairment charge of $1,004 related to leasehold improvements due to the relocation of our New York based BluePrint manufacturing facility for the fiscal year ended June 30, 2015.

The Company’s net sales by product category are as follows:



	Fiscal Year ended June 30,
	2017		2016		2015
Grocery	$	1,743,860	$	1,800,640	$	1,724,675
Poultry/Protein	509,606		492,510		337,197
Snacks	312,784		307,797		291,719
Personal Care	176,408		171,669		135,627
Tea	110,453		112,758		120,395
Total	$	2,853,111	$	2,885,374	$	2,609,613

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows:



	Fiscal Year ended June 30,
	2017		2016		2015
United States	$	1,677,294	$	1,729,751	$	1,582,553
United Kingdom	851,757		859,183		803,470
All Other	324,060		296,440		223,590
Total	$	2,853,111	$	2,885,374	$	2,609,613

The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic region are as follows:



	Fiscal Year ended June 30,
	2017		2016
United States	$	194,348	$	193,192
United Kingdom	165,396		196,271
All Other	63,330		53,260
Total	$	423,074	$	442,723

Quarterly Financial Data (Unaudited)

12 Months Ended

Jun. 30, 2017

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Data (Unaudited)

QUARTERLY FINANCIAL DATA (UNAUDITED)

A summary of the Company’s consolidated quarterly results of operations is as follows. The sum of the net income per share from continuing operations for each of the four quarters may not equal the net income per share for the full year, as presented, due to rounding.



	Three Months Ended
	June 30, 2017		March 31, 2017		December 31, 2016		September 30, 2016
Net sales	$	725,085	$	706,563	$	739,999	$	681,464
Gross profit	$	149,719	$	143,393	$	138,393	$	109,867
Operating income	$	8,587	$	47,067	$	41,400	$	13,751
Income before income taxes and equity in earnings of equity-method investees	$	2,749	$	39,556	$	37,656	$	9,182
Net income	$	313	$	31,328	$	27,185	$	8,604

Net income per common share:
Basic	$	—	$	0.30	$	0.26	$	0.08
Diluted	$	—	$	0.30	$	0.26	$	0.08

The quarter ended June 30, 2017 was impacted by impairment charges of $14,079 ($10,733 net of tax) related to indefinite-lived intangible assets (tradenames), as well as a $26,373 ($20,877 net of tax) impairment charge primarily related to long-lived assets associated with the exit of certain portions of our own-label chilled desserts business in the United Kingdom. Additionally, the quarter ended June 30, 2017 was impacted by $9,473 ($6,773 net of tax) related to professional fees associated with our internal accounting review.

The quarters ended March 31, 2017, December 31, 2016 and September 30, 2016 were impacted by $7,124 ($5,029 net of tax), $7,005 ($5,050 net of tax), and $5,960 ($4,112 net of tax), respectively, related to professional fees associated with our internal accounting review.



	Three Months Ended
	June 30, 2016			March 31, 2016		December 31, 2015		September 30, 2015
Net sales	$	737,547		$	736,663	$	743,437	$	667,727
Gross profit	$	150,081		$	159,908	$	166,261	$	137,881
Operating income (loss)	$	(65,138	)	$	71,148	$	90,078	$	54,272
Income/(loss) before income taxes and equity in earnings of equity-method investees	$	(77,572	)	$	72,863	$	80,713	$	42,404
Net income (loss)	$	(88,597	)	$	48,788	$	58,080	$	29,158

Net income (loss) per common share:
Basic	$	(0.86	)	$	0.47	$	0.56	$	0.28
Diluted	$	(0.86	)	$	0.47	$	0.56	$	0.28

The quarter ended June 30, 2016 was impacted by goodwill impairment charges recorded of $84,548 in the United Kingdom, impairment charges of $39,724 ($30,772 net of tax) related to indefinite-lived intangible assets (tradenames), as well as a $3,476 ($2,855 net of tax) impairment charge related to long-lived assets associated with the divestiture of certain portions of our own-label juice business in connection with our acquisition of Orchard House in the United Kingdom.

The quarter ended March 31, 2016 was impacted by a $9,013 ($6,231 net of tax) gain on fire insurance recovery as a result of fixed assets purchased with insurance proceeds that exceeded the net book value of fixed assets destroyed in the fire that occurred at our Tilda rice milling facility in the second quarter of fiscal 2015.

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Jun. 30, 2017

Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation and Qualifying Accounts

The Hain Celestial Group, Inc. and Subsidiaries

Schedule II - Valuation and Qualifying Accounts



Column A	Column B		Column C				Column D			Column E
			Additions
	Balance at beginning of period		Charged to costs and expenses		Charged to other accounts - describe (i)		Deductions - describe (ii)			Balance at end of period
Fiscal Year Ended June 30, 2017:
Allowance for doubtful accounts	$	936	$	1,077	$	149	$	(715	)	$	1,447
Valuation allowance for deferred tax assets	$	15,310	$	1,862	$	—	$	(2,322	)	$	14,850

Fiscal Year Ended June 30, 2016:
Allowance for doubtful accounts	$	896	$	208	$	54	$	(222	)	$	936
Valuation allowance for deferred tax assets	$	10,926	$	7,484	$	—	$	(3,100	)	$	15,310

Fiscal Year Ended June 30, 2015:
Allowance for doubtful accounts	$	1,586	$	791	$	20	$	(1,501	)	$	896
Valuation allowance for deferred tax assets	$	10,952	$	963	$	—	$	(989	)	$	10,926


(i)	Represents the allowance for doubtful accounts of the business acquired during the fiscal year


(ii)	Amounts written off and changes in exchange rates

Summary of Significant Accounting Policies and Practices (Policies)

12 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Segment Reporting

With a proven track record of strategic growth and profitability, the Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-for-you” products, providing consumers with the opportunity to lead A Healthier Way of Life^TM. Hain Celestial is a leader in many organic and natural products categories, with many recognized brands in the various market categories it serves, including Almond Dream^®, Arrowhead Mills^®, Bearitos^®, Better Bean^TM, BluePrint^®, Celestial Seasonings^®, Coconut Dream^®, Cully & Sully^®, Danival^®, DeBoles^®, Earth’s Best^®, Ella’s Kitchen^®, Empire^®, Europe’s Best^®, Farmhouse Fare^®, Frank Cooper’s^®, FreeBird^®, Gale’s^®, Garden of Eatin’^®, GG UniqueFiber^TM, Hain Pure Foods^®, Hartley’s^®, Health Valley^®, Imagine^®, Johnson’s Juice Co.^®, Joya^®, Kosher Valley^®, Lima^®, Linda McCartney’s^® (under license), MaraNatha^®, Natumi^®, New Covent Garden Soup Co.^®, Plainville Farms^®, Rice Dream^®, Robertson’s^®, Rudi’s Gluten-Free Bakery^®, Rudi’s Organic Bakery^®, Sensible Portions^®, Spectrum Organics^®, Soy Dream^®, Sun-Pat^®, SunSpire^®, Terra^®, The Greek Gods^®, Tilda^®, Walnut Acres^®, WestSoy^®, Yorkshire Provender^TM and Yves Veggie Cuisine^®. The Company’s personal care products are marketed under the Alba Botanica^®, Avalon Organics^®, Earth’s Best^®, JASON^®, Live Clean^® and Queen Helene^® brands.

Reclassifications

Certain prior year amounts have been reclassified to conform with current year presentation.

Use of Estimates

The financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. These estimates include, among others, revenue recognition, trade promotions and sales incentives, valuation of accounts and chargeback receivables, accounting for acquisitions, valuation of long-lived assets, goodwill and intangible assets, stock-based compensation, and valuation allowances for deferred tax assets. We believe in the quality and reasonableness of our critical accounting estimates; however, materially different amounts may be reported under different conditions or using assumptions different from those that we have consistently applied.

Cash and Cash Equivalents

Revenue Recognition

Trade Promotions and Sales Incentives

Valuation of Accounts and Chargebacks Receivable and Concentration of Credit Risk

Inventory

Property, Plant and Equipment



Buildings and improvements		10 - 40 years
Machinery and equipment		3 - 20 years
Furniture and fixtures		3 - 15 years

Leasehold improvements are amortized over the shorter of the respective initial lease term or the estimated useful life of the assets, and generally range from 3 to 15 years.

Goodwill and Other Indefinite-Lived Intangible Assets

See Note 7, Goodwill and Other Intangible Assets, for information on goodwill and intangibles impairment charges.

Cost of Sales

Foreign Currency Translation and Remeasurement

Selling, General and Administrative Expenses

Research and Development Costs

Advertising Costs

Income Taxes

Fair Value of Financial Instruments


•	Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;


•	Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and


•	Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

Derivative Instruments

Stock-based Compensation

Stock-Based Compensation

Valuation of Long-Lived Assets

See Note 6, Property, Plant and Equipment, Net for information on long-lived asset impairment charges.

Net Income Per Share

Recently Issued Accounting Pronouncements Not Yet Effective

The Company is currently evaluating the potential effects of adopting the provisions of ASU 2016-16.

Summary of Significant Accounting Policies and Practices (Tables)

12 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Summary of Property, Plant, and Equipment Useful Lives

The Company utilizes the following ranges of asset lives:



Buildings and improvements		10 - 40 years
Machinery and equipment		3 - 20 years
Furniture and fixtures		3 - 15 years

Property, plant and equipment, net consisted of the following:



	June 30, 2017		June 30, 2016
Land	$	33,930	$	35,825
Buildings and improvements	116,723		102,086
Machinery and equipment	350,689		358,362
Computer hardware and software	51,486		48,829
Furniture and fixtures	15,993		14,165
Leasehold improvements	29,296		28,471
Construction in progress	16,119		14,495
	614,236		602,233
Less: Accumulated depreciation and amortization	243,725		212,392
	$	370,511	$	389,841

Earnings Per Share (Tables)

12 Months Ended

Jun. 30, 2017

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share:



	Fiscal Year Ended June 30,
	2017		2016		2015
Numerator:
Net income	$	67,430	$	47,429	$	164,962

Denominator:
Basic weighted average shares outstanding	103,611		103,135		101,703
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units	637		1,048		1,718
Diluted weighted average shares outstanding	104,248		104,183		103,421

Net income per common share:
Basic	$	0.65	$	0.46	$	1.62
Diluted	$	0.65	$	0.46	$	1.60

Acquisitions Acquisitions (Tables)

12 Months Ended

Jun. 30, 2017

Business Combinations [Abstract]

Summary of Unaudited Pro Forma Results of Continuing Operations



	Fiscal Year Ended June 30,
	2016		2015
Net sales from continuing operations	$	2,973,872	$	2,947,536
Net income from continuing operations	$	51,270	$	177,435
Net income per common share from continuing operations - diluted	$	0.49	$	1.71



	Fiscal Year Ended June 30, 2015
Net sales from continuing operations	$	2,718,466
Net income from continuing operations	$	168,196
Net income per common share from continuing operations - diluted	$	1.63

Inventories (Tables)

12 Months Ended

Jun. 30, 2017

Inventory, Net [Abstract]

Components of Inventories

Inventories consisted of the following:



	June 30, 2017		June 30, 2016
Finished goods	$	264,148	$	238,184
Raw materials, work-in-progress and packaging	163,160		170,380
	$	427,308	$	408,564

Property, Plant And Equipment, Net (Tables)

12 Months Ended

Jun. 30, 2017

Property, Plant and Equipment [Abstract]

Summary of Property, Plant, and Equipment, Net

The Company utilizes the following ranges of asset lives:



Buildings and improvements		10 - 40 years
Machinery and equipment		3 - 20 years
Furniture and fixtures		3 - 15 years

Property, plant and equipment, net consisted of the following:



	June 30, 2017		June 30, 2016
Land	$	33,930	$	35,825
Buildings and improvements	116,723		102,086
Machinery and equipment	350,689		358,362
Computer hardware and software	51,486		48,829
Furniture and fixtures	15,993		14,165
Leasehold improvements	29,296		28,471
Construction in progress	16,119		14,495
	614,236		602,233
Less: Accumulated depreciation and amortization	243,725		212,392
	$	370,511	$	389,841

Goodwill And Other Intangible Assets (Tables)

12 Months Ended

Jun. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Changes In Carrying Amount Of Goodwill

The following table shows the changes in the carrying amount of goodwill by business segment:



	United States			United Kingdom			Hain Pure Protein		Rest of World			Total
Balance as of June 30, 2015 (a):	$	610,745		$	420,721		$	41,970	$	62,242		$	1,135,678
Acquisitions	—			57,019			(881)		20,674			76,812
Impairment charge	—			(84,548		)	—		—			(84,548		)
Translation and other adjustments, net	(5,043		)	(60,631		)	—		(1,932		)	(67,606		)
Balance as of June 30, 2016 (b):	605,702			332,561			41,089		80,984			1,060,336
Acquisitions	3,083			6,962			—		—			10,045
Reallocation of goodwill between reporting units	(16,377		)	—			—		16,377			—
Translation and other adjustments, net	(992		)	(10,388		)	—		980			(10,400		)
Balance as of June 30, 2017 (b):	$	591,416		$	329,135		$	41,089	$	98,341		$	1,059,981

Components Of Other Intangible Assets

The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and intangible assets not subject to amortization:



	June 30, 2017			June 30, 2016
Non-amortized intangible assets:
Trademarks and tradenames (a)	$	424,817		$	441,140
Amortized intangible assets:
Other intangibles	247,712			245,040
Less: accumulated amortization	(99,261		)	(81,393		)
Net carrying amount	$	573,268		$	604,787

(a) The gross carrying value of trademarks and tradenames is reflected net of $60,202 and $46,123 of accumulated impairment charges for the fiscal years ended June 30, 2017 and 2016, respectively.

Summary of Amortization Expense

Amortization expense included in continuing operations was as follows:



	Fiscal Year ended June 30,
	2017		2016		2015
Amortization of intangible assets	$	18,402	$	18,869	$	17,846

Summary of Expected Amortization Expense Over the Next Five Years

Expected amortization expense over the next five fiscal years is as follows:



	Fiscal Year ending June 30,
	2018		2019		2020		2021		2022
Estimated amortization expense	$	18,385	$	16,129	$	14,748	$	14,306	$	14,210

Accrued Expenses and Other Current Liabilities (Tables)

12 Months Ended

Jun. 30, 2017

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:



	June 30, 2017		June 30, 2016
Payroll, employee benefits and other administrative accruals	$	70,740	$	43,774
Freight and warehousing accruals	20,294		16,007
Selling and marketing related accruals	9,785		9,826
Other accruals	7,695		9,196
	$	108,514	$	78,803

Debt and Borrowings Debt and Borrowings (Tables)

12 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Summary of Debt and Borrowings

Debt and borrowings consisted of the following:



	June 30, 2017		June 30, 2016
Credit Agreement borrowings payable to banks	$	733,715	$	827,860
Tilda short-term borrowing arrangements	7,761		19,121
Other borrowings	8,672		15,703
	750,148		862,684
Short-term borrowings and current portion of long-term debt	9,844		26,513
Long-term debt, less current portion	$	740,304	$	836,171

Summary of Maturities of Debt Instruments

Maturities of all debt instruments at June 30, 2017, are as follows:



Due in Fiscal Year	Amount
2018	$	9,844
2019	1,829
2020	735,865
2021	1,891
2022	426
Thereafter	293
	$	750,148

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21521-112644

+ Details

Income Taxes (Tables)

12 Months Ended

Jun. 30, 2017

Income Tax Disclosure [Abstract]

Summary of Components of Income Before Taxes and Equity in Earnings of Equity-Method Investments

The components of income (loss) before income taxes and equity in earnings of equity-method investees were as follows:



	Fiscal Year Ended June 30,
	2017		2016			2015
Domestic	$	49,046	$	158,025		$	170,884
Foreign	40,097		(39,617		)	41,985
Total	$	89,143	$	118,408		$	212,869

Summary of the Provision for Income Taxes

The provision (benefit) for income taxes consisted of the following:



	Fiscal Year Ended June 30,
	2017			2016			2015
Current:
Federal	$	14,448		$	21,304		$	32,910
State and local	2,966			1,798			8,311
Foreign	14,884			14,737			9,981
	32,298			37,839			51,202
Deferred:
Federal	(3,199		)	30,711			(912		)
State and local	961			5,017			(1,069		)
Foreign	(8,218		)	(2,635		)	(686		)
	(10,456		)	33,093			(2,667		)
Total	$	21,842		$	70,932		$	48,535

Reconciliation of Expected Income Taxes to Actual

The reconciliation of the U.S. federal statutory rate to our effective rate on income before provision for income taxes was as follows:



	Fiscal Year Ended June 30,
	2017			%			2016				%		2015			%
Expected United States federal income tax at statutory rate	$	31,200		35.0	%		$	41,443			35.0	%	$	74,504		35.0	%
State income taxes, net of federal benefit	3,034			3.4	%		5,447				4.6	%	4,795			2.2	%
Domestic manufacturing deduction	(1,691		)	(1.9	)%		(1,233		)		(1.0	)%	(1,210		)	(0.6	)%
Foreign income at different rates	(6,539		)	(7.3	)%		(4,051		)		(3.4	)%	(9,515		)	(4.5	)%
Impairment of goodwill and intangibles	—			—	%	—	23,172			—	19.6	%	—			—	%
Change in valuation allowance	(60		)	(0.1	)%		5,067				4.3	%	963			0.5	%
Corporate tax reorganization	—			—	%		(4,173		)		(3.5	)%	(20,670		)	(9.7	)%
Unrealized foreign exchange losses	807			0.9	%		7,056				6.0	%	—			—	%
Change in reserves for uncertain tax positions	(4,417		)	(5.0	)%		1,448				1.2	%	(635		)	(0.3	)%
Non-taxable gains on acquisition of pre-existing ownership interests in HPPC and Empire	—			—	%		—				—	%	(2,793		)	(1.3	)%
Reduction of deferred tax liabilities resulting from change in United Kingdom tax rate	(1,841		)	(2.1	)%		(4,942		)		(4.2	)%	—			—	%
Other	1,349			1.6	%		1,698				1.3	%	3,096			1.5	%
Provision for income taxes	$	21,842		24.5	%		$	70,932			59.9	%	$	48,535		22.8	%

Schedule of Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities consisted of the following:



	June 30, 2017			June 30, 2016
Noncurrent deferred tax assets/(liabilities):
Basis difference on inventory	$	10,933		$	11,232
Reserves not currently deductible	23,757			17,652
Basis difference on intangible assets	(145,558		)	(145,673		)
Basis difference on property and equipment	(20,137		)	(25,933		)
Other comprehensive income	(768		)	(4,623		)
Net operating loss and tax credit carryforwards	22,197			25,340
Stock based compensation	3,996			4,632
Other	(616		)	1,176
Valuation allowances	(14,850		)	(15,310		)
Noncurrent deferred tax liabilities, net	(121,046		)	(131,507		)

Total net deferred tax liabilities	$	(121,046	)	$	(131,507	)


(1)	The June 30, 2017 balance sheet includes $429 of non-current deferred tax assets in Other Assets.

Summary of Changes in Valuation Allowances

The changes in valuation allowances against deferred income tax assets were as follows:



	Fiscal Year Ended June 30,
	2017			2016
Balance at beginning of year	$	15,310		$	10,926
Additions charged to income tax expense	1,862			7,484
Reductions credited to income tax expense	(1,922		)	(2,417		)
Currency translation adjustments	(400		)	(683		)
Balance at end of year	$	14,850		$	15,310

Schedule of Unrecognized Tax Benefits, Including Interest and Penalties Activity

Unrecognized tax benefits activity, including interest and penalties, is summarized below:



	Fiscal Year Ended June 30,
	2017			2016			2015
Balance at beginning of year	$	16,019		$	10,759		$	11,058
Additions based on tax positions related to the current year	217			4,276			1,089
Additions based on tax positions related to prior years	—			1,404			202
Reductions due to lapse in statute of limitations and settlements	(4,634		)	(420		)	(1,590		)
Balance at end of year	$	11,602		$	16,019		$	10,759

Stockholders' Equity (Tables)

12 Months Ended

Jun. 30, 2017

Equity [Abstract]

Summary of Changes in Accumulated Other Comprehensive Loss

The following tables present the changes in accumulated other comprehensive loss:



	Fiscal Year Ended June 30,
	2017			2016
Foreign currency translation adjustments:
Other comprehensive loss before reclassifications ⁽¹⁾	$	(22,951	)	$	(129,874	)
Deferred gains/(losses) on cash flow hedging instruments:
Other comprehensive income before reclassifications	196			4,666
Amounts reclassified into income ⁽²⁾	(575		)	(5,193		)
Unrealized gain on available for sale investment:
Other comprehensive loss before reclassifications	(51		)	(79		)
Amounts reclassified into income ⁽³⁾	13			—
Net change in accumulated other comprehensive loss	$	(23,368	)	$	(130,480	)


(1)	Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term investment nature of $18,385 and $107,221 for the fiscal years ended June 30, 2017 and 2016, respectively.


(2)	Amounts reclassified into income for deferred gains on cash flow hedging instruments are recorded in “Cost of sales” in the Consolidated Statements of Income and, before taxes, were $1,233 and $6,788 for the fiscal years ended June 30, 2017 and 2016, respectively.

(3)

Stock Based Compensation And Incentive Performance Plans (Tables)

12 Months Ended

Jun. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Compensation Cost And Related Income Tax Benefits Recognized

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Income for stock based compensation plans were as follows:



	Fiscal Year Ended June 30,
	2017		2016		2015
Compensation cost (included in selling, general and administrative expense)	$	9,658	$	12,688	$	12,197
Related income tax benefit	$	3,622	$	4,758	$	4,695

Summary Of Stock Option Activity

A summary of the stock option activity for the three fiscal years ended June 30 is as follows:



	2017		Weighted Average Exercise Price		2016		Weighted Average Exercise Price		2015		Weighted Average Exercise Price
Outstanding at beginning of year	342		$	6.66	1,249		$	6.12	2,674		$	9.83
Exercised	(220	)	$	9.10	(907	)	$	5.91	(1,425	)	$	13.08
Outstanding at end of year	122		$	2.26	342		$	6.66	1,249		$	6.12

Options exercisable at end of year	122		$	2.26	342		$	6.66	1,249		$	6.12



	Fiscal Year Ended June 30,
	2017		2016		2015
Intrinsic value of options exercised	$	6,507	$	27,147	$	62,213
Cash received from stock option exercises	$	—	$	—	$	18,643
Tax benefit recognized from stock option exercises	$	2,538	$	10,587	$	24,213

Non-Vested Restricted Stock And Restricted Share Unit Awards

A summary of the restricted stock and restricted share units activity for the three fiscal years ended June 30 is as follows:



	2017		Weighted Average Grant Date Fair Value (per share)	2016		Weighted Average Grant Date Fair Value (per share)	2015		Weighted Average Grant Date Fair Value (per share)
Non-vested restricted stock and restricted share units - beginning of year	1,121		$28.24	1,145		$32.30	1,259		$25.44
Granted	195		$33.68	416		$24.54	311		$54.11
Vested	(290	)	$33.89	(408	)	$35.13	(402	)	$26.86
Forfeited	(34	)	$29.88	(32	)	$45.83	(23	)	$40.65
Non-vested restricted stock and restricted share units - end of year	992		$27.59	1,121		$28.24	1,145		$32.30

Restricted Stock Grant Information



	Fiscal Year Ended June 30,
	2017		2016		2015
Fair value of restricted stock and restricted share units granted	$	6,567	$	10,203	$	16,462
Fair value of shares vested	$	9,866	$	18,917	$	21,481
Tax benefit recognized from restricted shares vesting	$	3,768	$	7,139	$	8,364

Financial Instruments Measured At Fair Value (Tables)

12 Months Ended

Jun. 30, 2017

Fair Value Disclosures [Abstract]

Assets And Liabilities Measured At Fair Value On A Recurring Basis

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2017:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	21,800	$	21,800	$	—	$	—
Forward foreign currency contracts	99		—		99		—
Available for sale securities	882		882		—		—
	$	22,781	$	22,682	$	99	$	—
Liabilities:
Forward foreign currency contracts	$	53	$	—	$	53	$	—
Contingent consideration, noncurrent	2,656		—		—		2,656
Total	$	2,709	$	—	$	53	$	2,656

The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2016:



	Total		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	$	20,706	$	20,706	$	—	$	—
Forward foreign currency contracts	531		—		531		—
Available for sale securities	1,067		1,067		—		—
	$	22,304	$	21,773	$	531	$	—
Liabilities:
Contingent consideration, current	3,553		—		—		3,553
Total	$	3,553	$	—	$	—	$	3,553

Summary of Level 3 Activity

The following table summarizes the Level 3 activity:



	Fiscal Year ended June 30,
	2017			2016
Balance at beginning of year	$	3,553		$	1,636
Fair value of initial contingent consideration	2,652			2,225
Contingent consideration adjustments	526			1,511
Contingent consideration paid	(3,969		)	(1,547		)
Translation adjustment	(106		)	(272		)
Balance at end of year	$	2,656		$	3,553

Commitments And Contingencies (Tables)

12 Months Ended

Jun. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Summary of Minimum Future Lease Payments

The aggregate minimum future lease payments for these operating leases at June 30, 2017 are as follows:



Fiscal Year
2018	$	18,771
2019	14,831
2020	12,615
2021	9,401
2022	8,516
Thereafter	37,702
	$	101,836

Segment Information (Tables)

12 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

The following tables set forth financial information about each of the Company’s reportable segments. Transactions between reportable segments were insignificant for all periods presented.



	Fiscal Years ended June 30,
	2017			2016			2015
Net Sales: ⁽¹⁾
United States	$	1,191,262		$	1,249,123		$	1,253,156
United Kingdom	768,301			774,877			722,830
Hain Pure Protein	509,606			492,510			337,197
Rest of World	383,942			368,864			296,430
	$	2,853,111		$	2,885,374		$	2,609,613

Operating Income:
United States	$	157,506		$	203,481		$	180,937
United Kingdom	39,749			56,000			44,985
Hain Pure Protein	1,382			31,558			28,685
Rest of World	32,010			27,898			22,327
	230,647			318,937			276,934
Corporate and Other ⁽²⁾	(119,842		)	(168,577		)	(43,072		)
	$	110,805		$	150,360		$	233,862

(1)

(2)

Summary of Revenue by Product Category

The Company’s net sales by product category are as follows:



	Fiscal Year ended June 30,
	2017		2016		2015
Grocery	$	1,743,860	$	1,800,640	$	1,724,675
Poultry/Protein	509,606		492,510		337,197
Snacks	312,784		307,797		291,719
Personal Care	176,408		171,669		135,627
Tea	110,453		112,758		120,395
Total	$	2,853,111	$	2,885,374	$	2,609,613

Summary of Net Sales by Geographic Areas

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows:



	Fiscal Year ended June 30,
	2017		2016		2015
United States	$	1,677,294	$	1,729,751	$	1,582,553
United Kingdom	851,757		859,183		803,470
All Other	324,060		296,440		223,590
Total	$	2,853,111	$	2,885,374	$	2,609,613

Schedule of Long Lived Assets, by Geographic Region

The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic region are as follows:



	Fiscal Year ended June 30,
	2017		2016
United States	$	194,348	$	193,192
United Kingdom	165,396		196,271
All Other	63,330		53,260
Total	$	423,074	$	442,723

Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Jun. 30, 2017

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Data



	Three Months Ended
	June 30, 2017		March 31, 2017		December 31, 2016		September 30, 2016
Net sales	$	725,085	$	706,563	$	739,999	$	681,464
Gross profit	$	149,719	$	143,393	$	138,393	$	109,867
Operating income	$	8,587	$	47,067	$	41,400	$	13,751
Income before income taxes and equity in earnings of equity-method investees	$	2,749	$	39,556	$	37,656	$	9,182
Net income	$	313	$	31,328	$	27,185	$	8,604

Net income per common share:
Basic	$	—	$	0.30	$	0.26	$	0.08
Diluted	$	—	$	0.30	$	0.26	$	0.08



	Three Months Ended
	June 30, 2016			March 31, 2016		December 31, 2015		September 30, 2015
Net sales	$	737,547		$	736,663	$	743,437	$	667,727
Gross profit	$	150,081		$	159,908	$	166,261	$	137,881
Operating income (loss)	$	(65,138	)	$	71,148	$	90,078	$	54,272
Income/(loss) before income taxes and equity in earnings of equity-method investees	$	(77,572	)	$	72,863	$	80,713	$	42,404
Net income (loss)	$	(88,597	)	$	48,788	$	58,080	$	29,158

Net income (loss) per common share:
Basic	$	(0.86	)	$	0.47	$	0.56	$	0.28
Diluted	$	(0.86	)	$	0.47	$	0.56	$	0.28

Description of Business and Basis of Presentation (Details)	Jun. 30, 2017 country
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which company operates (more than)	80

Summary of Significant Accounting Policies and Practices (Valuation of Accounts and Chargebacks Receivable and Concentration of Credit Risk) (Details) - Customer Concentration Risk	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Trade Receivable
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%	10.00%
Sales \| First Customer
Concentration Risk [Line Items]
Concentration risk, percentage	10.00%	10.00%	10.00%
Sales \| Second Customer
Concentration Risk [Line Items]
Concentration risk, percentage	9.00%	10.00%	11.00%

Summary of Significant Accounting Policies and Practices (PPE Useful Life) (Details)	12 Months Ended
	Jun. 30, 2017
Minimum \| Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	10 years
Minimum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	3 years
Minimum \| Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	3 years
Minimum \| Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	3 years
Maximum \| Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	40 years
Maximum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	20 years
Maximum \| Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	15 years
Maximum \| Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life	15 years

Summary of Significant Accounting Policies and Practices (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended	12 Months Ended
	Oct. 25, 2014	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Business Interruption Loss [Line Items]
Gain on fire insurance recovery			$ 0	$ 9,752	$ 0
Research and development costs			10,149	11,354	10,271
Advertising costs			33,053	26,968	$ 26,061
Money market securities, fair value			$ 21,800	20,706
Tilda Milling Facility Fire
Business Interruption Loss [Line Items]
Gain on fire insurance recovery	$ 9,752	$ 9,013
Insurance settlements receivable				$ 4,234

Earnings Per Share (Computation Of Basic And Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Earnings Per Share [Abstract]
Net income	$ 313	$ 31,328	$ 27,185	$ 8,604	$ (88,597)	$ 48,788	$ 58,080	$ 29,158	$ 67,430	$ 47,429	$ 164,962
Denominator:
Basic weighted average shares outstanding (shares)									103,611	103,135	101,703
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units (shares)									637	1,048	1,718
Diluted weighted average shares outstanding (shares)									104,248	104,183	103,421
Basic (USD per share)	$ 0.00	$ 0.30	$ 0.26	$ 0.08	$ (0.86)	$ 0.47	$ 0.56	$ 0.28	$ 0.65	$ 0.46	$ 1.62
Diluted (USD per share)	$ 0.00	$ 0.30	$ 0.26	$ 0.08	$ (0.86)	$ 0.47	$ 0.56	$ 0.28	$ 0.65	$ 0.46	$ 1.60

Earnings Per Share (Narrative) (Details) - USD ($)	12 Months Ended
Earnings Per Share (Narrative) (Details) - USD ($)	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015	Jun. 21, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)		0	0
Authorized amount				$ 250,000,000
Remaining authorized repurchase amount	$ 250,000,000
Stock Based Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	271,000	282,000	107,000
Restricted Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	12,000

Acquisitions (Fiscal 2017) (Narrative) (Details)				12 Months Ended
Acquisitions (Fiscal 2017) (Narrative) (Details)	Jun. 19, 2017 USD ($)	Apr. 28, 2017 GBP (£)	Apr. 28, 2017 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)
Business Acquisition [Line Items]
Acquisition related costs				$ 2,035,000	$ 3,724,000	$ 5,731,000
Cash paid, net of cash acquired				19,544,000	$ 157,061,000	104,633,000
Trade Names
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired				3,673,000		43,747,000
Customer Relationships
Business Acquisition [Line Items]
Acquired finite-lived intangible assets				$ 7,045,000		$ 15,903,000
Acquired finite-lived intangible assets, weighted average useful life				14 years		11 years
Better Bean
Business Acquisition [Line Items]
Cash paid, net of cash acquired	$ 3,434,000
Contingent consideration, high range	$ 4,000,000
Contingent consideration arrangements, period for achievement operating results	3 years			3 years
Better Bean \| Sales
Business Acquisition [Line Items]
Concentration risk, percentage, less then				1.00%
Yorkshire Provender
Business Acquisition [Line Items]
Cash paid, net of cash acquired		£ 12,465,000	$ 16,110,000
Contingent consideration, high range \| £		£ 1,500,000
Contingent consideration arrangements, period for achievement operating results		3 years	3 years
Yorkshire Provender \| Sales
Business Acquisition [Line Items]
Concentration risk, percentage, less then				1.00%

Acquisitions (Fiscal 2016) (Narrative) (Details) € in Thousands, shares in Thousands, $ in Thousands						12 Months Ended
	Sep. 15, 2016 GBP (£)	Dec. 21, 2015 GBP (£)	Dec. 21, 2015 USD ($)	Jul. 24, 2015 USD ($) shares	Jul. 24, 2015 EUR (€) shares	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)
Business Acquisition [Line Items]
Cash paid, net of cash acquired						$ 19,544	$ 157,061	$ 104,633
Contingent consideration paid						3,969	1,547
Trade Names
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired						3,673		43,747
Customer Relationships
Business Acquisition [Line Items]
Acquired finite-lived intangible assets						$ 7,045		$ 15,903
Acquired finite-lived intangible assets, weighted average useful life						14 years		11 years
FY'16 Acquisitions \| Trade Names
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired							10,965
FY'16 Acquisitions \| Customer Relationships
Business Acquisition [Line Items]
Acquired finite-lived intangible assets							$ 58,726
Acquired finite-lived intangible assets, weighted average useful life							15 years
Orchard House
Business Acquisition [Line Items]
Cash paid, net of cash acquired		£ 76,923,000	$ 114,113
Business combination, contingent consideration \| £		£ 3,000,000
Contingent consideration paid \| £	£ 1,500,000
Net sales							$ 88,580
Income before income taxes							4,622
Mona
Business Acquisition [Line Items]
Cash paid, net of cash acquired				$ 24,948	€ 22,753
Net sales							58,767
Income before income taxes							$ 3,464
Equity interest issued in business combination (shares) \| shares				240	240
Equity interest issued in business combination, value				$ 16,308
Debt assumed in business combination \| €					€ 16,252

Acquisitions Acquisitions (Pro Forma Results) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
FY'16 Acquisitions
Business Acquisition [Line Items]
Net sales from continuing operations	$ 2,973,872	$ 2,947,536
Net income from continuing operations	$ 51,270	$ 177,435
Net income per common share from continuing operations - diluted (USD per share)	$ 0.49	$ 1.71
FY'15 Acquisitions
Business Acquisition [Line Items]
Net sales from continuing operations		$ 2,718,466
Net income from continuing operations		$ 168,196
Net income per common share from continuing operations - diluted (USD per share)		$ 1.63

Acquisitions Acquisitions (Fiscal 2015) (Narrative) (Details) shares in Thousands, $ in Thousands					3 Months Ended		12 Months Ended
	Mar. 04, 2015 USD ($)	Feb. 20, 2015 USD ($) period product	Feb. 20, 2015 CAD ($) period product	Jul. 17, 2014 USD ($) shares	Jun. 30, 2017 CAD ($)	Jun. 30, 2016 CAD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2016 CAD ($)	Jun. 30, 2015 USD ($)	Jun. 30, 2014 USD ($)
Business Acquisition [Line Items]
Cash paid, net of cash acquired							$ 19,544	$ 157,061		$ 104,633
Investments and joint ventures							18,998	20,244
Gains on pre-existing ownership interests in HPPC and Empire							0	0		9,669
Contingent consideration paid							3,969	$ 1,547
Trade Names
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired							3,673			43,747
Customer Relationships
Business Acquisition [Line Items]
Acquired finite-lived intangible assets							$ 7,045			$ 15,903
Acquired finite-lived intangible assets, weighted average useful life							14 years			11 years
Patents
Business Acquisition [Line Items]
Acquired finite-lived intangible assets										$ 1,700
Acquired finite-lived intangible assets, weighted average useful life										9 years
HPPC
Business Acquisition [Line Items]
Business combination, voting interest acquired				51.30%
Cash paid, net of cash acquired				$ 20,310
Equity interest issued in business combination (shares) \| shares				463
Equity interest issued in business combination, value				$ 19,690
Equity method investment, ownership percentage											48.70%
Investments and joint ventures											$ 29,327
Gains on pre-existing ownership interests in HPPC and Empire				$ 6,747
Net sales										$ 290,593
Income before income taxes										26,649
Belvedere
Business Acquisition [Line Items]
Cash paid, net of cash acquired		$ 13,988	$ 17,454,000
Number of products \| product		200	200
Contingent consideration, high range			$ 4,000,000
Contingent consideration arrangements, number of periods for achievement operating results \| period		2	2
Contingent consideration arrangements, period for achievement operating results		1 year	1 year
Contingent consideration paid					$ 2,000,000	$ 2,000,000			$ 2,000,000
Belvedere \| Sales
Business Acquisition [Line Items]
Concentration risk, percentage, less then							1.00%
Empire
Business Acquisition [Line Items]
Business combination, voting interest acquired	81.00%			19.00%
Cash paid, net of cash acquired	$ 57,595
Gains on pre-existing ownership interests in HPPC and Empire	2,922
Net sales										46,604
Income before income taxes										$ 4,752
Noncontrolling interest	$ 6,864

Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
Inventory, Net [Abstract]
Finished goods	$ 264,148	$ 238,184
Raw materials, work-in-progress and packaging	163,160	170,380
Total inventories	$ 427,308	$ 408,564

Property, Plant And Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 614,236	$ 614,236	$ 602,233
Less: Accumulated depreciation and amortization	243,725	243,725	212,392
Property, plant and equipment, net	370,511	370,511	389,841
Depreciation		40,824	38,124	$ 32,293
Impairment charge related to long-lived assets	23,712			$ 1,004
United States
Property, Plant and Equipment [Line Items]
Impairment charge related to long-lived assets	2,661
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	33,930	33,930	35,825
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	116,723	116,723	102,086
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	350,689	350,689	358,362
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	51,486	51,486	48,829
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	15,993	15,993	14,165
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	29,296	29,296	28,471
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 16,119	$ 16,119	$ 14,495

Goodwill And Other Intangible Assets (Changes In Carrying Amount Of Goodwill) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Goodwill
Goodwill		$ 1,060,336	$ 1,135,678
Acquisitions		10,045	76,812
Impairment charge		0	(84,548)	$ 0
Reallocation of goodwill between reporting units		0
Translation and other adjustments, net		(10,400)	(67,606)
Goodwill	$ 1,060,336	1,059,981	1,060,336	1,135,678
Accumulated impairment charge	42,029	126,577	42,029	42,029
United States
Goodwill
Goodwill		605,702	610,745
Acquisitions		3,083	0
Impairment charge			0
Reallocation of goodwill between reporting units		(16,377)
Translation and other adjustments, net		(992)	(5,043)
Goodwill	605,702	591,416	605,702	610,745
United Kingdom
Goodwill
Goodwill		332,561	420,721
Acquisitions		6,962	57,019
Impairment charge	(84,548)		(84,548)
Reallocation of goodwill between reporting units		0
Translation and other adjustments, net		(10,388)	(60,631)
Goodwill	332,561	329,135	332,561	420,721
Accumulated impairment charge	12,810	97,358	12,810	12,810
Hain Pure Protein
Goodwill
Goodwill		41,089	41,970
Acquisitions		0	(881)
Impairment charge			0
Reallocation of goodwill between reporting units		0
Translation and other adjustments, net		0	0
Goodwill	41,089	41,089	41,089	41,970
Rest of World
Goodwill
Goodwill		80,984	62,242
Acquisitions		0	20,674
Impairment charge			0
Reallocation of goodwill between reporting units		16,377
Translation and other adjustments, net		980	(1,932)
Goodwill	80,984	98,341	80,984	62,242
Europe
Goodwill
Accumulated impairment charge	$ 29,219	$ 29,219	$ 29,219	$ 29,219

Goodwill And Other Intangible Assets (Narrative) (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Segment Reporting Information [Line Items]
Percentage of fair value in excess of carrying amount	20.00%		20.00%
Goodwill impairment			$ 0	$ 84,548,000	$ 0
Long-lived asset and intangibles impairment		$ 39,724,000	$ 40,452,000	43,200,000	1,004,000
Impairment charge indefinite-lived intangible assets					$ 0
Weighted average remaining amortization period			10 years 4 months
Minimum
Segment Reporting Information [Line Items]
Finite-lived intangible asset, useful life			3 years
Maximum
Segment Reporting Information [Line Items]
Finite-lived intangible asset, useful life			25 years
Other Segments
Segment Reporting Information [Line Items]
Goodwill impairment				82,614,000
United Kingdom
Segment Reporting Information [Line Items]
Goodwill impairment		$ 84,548,000		84,548,000
Long-lived asset and intangibles impairment	$ 26,373,000		$ 26,373,000
United States
Segment Reporting Information [Line Items]
Goodwill impairment				0
Orchard House
Segment Reporting Information [Line Items]
Goodwill impairment				$ 1,934,000

Goodwill And Other Intangible Assets (Components of Other Intangible Assets) (Details) - USD ($)	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Non-amortized intangible assets:
Trademarks and tradenames	$ 424,817,000	$ 441,140,000
Amortized intangible assets:
Other intangibles	247,712,000	245,040,000
Less: accumulated amortization	(99,261,000)	(81,393,000)
Net carrying amount	573,268,000	604,787,000
Impairment charge			$ 0
Trademarks and Tradenames
Amortized intangible assets:
Impairment charge	$ 60,202,000	$ 46,123,000

Goodwill And Other Intangible Assets (Amortization Expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 18,402	$ 18,869	$ 17,846

Goodwill And Other Intangible Assets (Expected Amortization Expense Over Next Five Fiscal Years) (Details) $ in Thousands	Jun. 30, 2017 USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2018	$ 18,385
2019	16,129
2020	14,748
2021	14,306
2022	$ 14,210

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
Payables and Accruals [Abstract]
Payroll, employee benefits and other administrative accruals	$ 70,740	$ 43,774
Freight and warehousing accruals	20,294	16,007
Selling and marketing related accruals	9,785	9,826
Other accruals	7,695	9,196
Accrued expenses and other current liabilities	$ 108,514	$ 78,803

Debt and Borrowings Debt and Borrowings (Schedule of Debt Balances) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
Debt Instrument [Line Items]
Other borrowings	$ 8,672	$ 15,703
Long-term debt	750,148	862,684
Short-term borrowings and current portion of long-term debt	9,844	26,513
Long-term debt, less current portion	740,304	836,171
Credit Agreement borrowings payable to banks
Debt Instrument [Line Items]
Borrowings outstanding under credit agreement	733,715	827,860
Tilda short-term borrowing arrangements
Debt Instrument [Line Items]
Borrowings outstanding under credit agreement	$ 7,761	$ 19,121

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References + Details

Debt and Borrowings (Narrative) (Details)		12 Months Ended
Debt and Borrowings (Narrative) (Details)	Dec. 12, 2014 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Jun. 30, 2017 GBP (£)	Jun. 30, 2017 USD ($)	Jun. 30, 2017 EUR (€)
Line of Credit Facility [Line Items]
Line of credit potential incremental borrowing capacity post-amendment	$ 350,000,000
Revolving credit facility expiration date	Dec. 12, 2019
Interest coverage ratio	4.0
Leverage ratio	3.5
Consolidated leverage ratio	4.0
Interest paid		$ 18,873,000	$ 24,288,000	$ 22,865,000
Credit Agreement borrowings payable to banks
Line of Credit Facility [Line Items]
Revolving credit facility	$ 1,000,000,000
Borrowing under letters of credit						$ 733,715,000
Remaining borrowing capacity						$ 260,105,000
Long-term debt, weighted average interest rate					2.93%	2.93%	2.93%
Letter of credit
Line of Credit Facility [Line Items]
Borrowing under letters of credit						$ 6,180,000
Tilda short-term borrowing arrangements
Line of Credit Facility [Line Items]
Revolving credit facility \| £					£ 52,000,000
Debt instrument, term		6 months
Short-term debt, weighted average interest rate					2.70%	2.70%	2.70%
Line of Credit
Line of Credit Facility [Line Items]
Revolving credit facility \| €							€ 12,500,000
Mona
Line of Credit Facility [Line Items]
Short-term debt, weighted average interest rate					1.10%	1.10%	1.10%
Minimum \| Credit Agreement borrowings payable to banks
Line of Credit Facility [Line Items]
Unused capacity, commitment fee, percentage	0.20%
Minimum \| Eurocurrency Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.875%
Minimum \| Base Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.00%
Maximum \| Credit Agreement borrowings payable to banks
Line of Credit Facility [Line Items]
Unused capacity, commitment fee, percentage	0.30%
Maximum \| Eurocurrency Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	1.70%
Maximum \| Base Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.70%

Debt and Borrowings (Maturities of Debt Instruments) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
Debt Disclosure [Abstract]
2018	$ 9,844
2019	1,829
2020	735,865
2021	1,891
2022	426
Thereafter	293
Long-term debt	$ 750,148	$ 862,684

Income Taxes (Components of Income Before Income Taxes) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Income Tax Disclosure [Abstract]
Domestic									$ 49,046	$ 158,025	$ 170,884
Foreign									40,097	(39,617)	41,985
Income before income taxes and equity in earnings of equity-method investees	$ 2,749	$ 39,556	$ 37,656	$ 9,182	$ (77,572)	$ 72,863	$ 80,713	$ 42,404	$ 89,143	$ 118,408	$ 212,869

Income Taxes (Provision for Income Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Current:
Federal	$ 14,448	$ 21,304	$ 32,910
State and local	2,966	1,798	8,311
Foreign	14,884	14,737	9,981
Current income tax expense	32,298	37,839	51,202
Deferred:
Federal	(3,199)	30,711	(912)
State and local	961	5,017	(1,069)
Foreign	(8,218)	(2,635)	(686)
Deferred income tax expense	(10,456)	33,093	(2,667)
Total	$ 21,842	$ 70,932	$ 48,535

Income Taxes Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2014
Operating Loss Carryforwards [Line Items]
Cash paid for income taxes, net of refunds	$ (2,900)	$ 44,225	$ 47,317
Tax credit carry forwards	877	877
Undistributed earnings of foreign subsidiaries	156,405
Valuation allowances	14,850	15,310	10,926
Unrecognized tax benefits	11,602	16,019	10,759	$ 11,058
Unrecognized tax benefits that would impact effective tax rate	6,409	10,826	$ 9,375
Interest and penalties, accrued	460	650
Decrease in unrecognized tax benefits, reasonably possible	3,754
Federal
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	33,177	38,433
Foreign
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 43,306	$ 42,573

Income Taxes (Reconciliation of Expected Income Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Effective Income Tax Rate Reconciliation, Amount
Expected United States federal income tax at statutory rate	$ 31,200	$ 41,443	$ 74,504
State income taxes, net of federal benefit	3,034	5,447	4,795
Domestic manufacturing deduction	(1,691)	(1,233)	(1,210)
Foreign income at different rates	(6,539)	(4,051)	(9,515)
Impairment of goodwill and intangibles	0	23,172	0
Change in valuation allowance	(60)	5,067	963
Corporate tax reorganization	0	(4,173)	(20,670)
Unrealized foreign exchange losses	807	7,056	0
Change in reserves for uncertain tax positions	(4,417)	1,448	(635)
Non-taxable gains on acquisition of pre-existing ownership interests in HPPC and Empire	0	0	(2,793)
Reduction of deferred tax liabilities resulting from change in United Kingdom tax rate	(1,841)	(4,942)	0
Other	1,349	1,698	3,096
Total	$ 21,842	$ 70,932	$ 48,535
Effective Income Tax Rate Reconciliation, Percent
Expected United States federal income tax at statutory rate	35.00%	35.00%	35.00%
State income taxes, net of federal benefit	3.40%	4.60%	2.20%
Domestic manufacturing deduction	(1.90%)	(1.00%)	(0.60%)
Foreign income at different rates	(7.30%)	(3.40%)	(4.50%)
Impairment of goodwill and intangibles	0.00%	19.60%	0.00%
Change in valuation allowance	(0.10%)	4.30%	0.50%
Corporate tax reorganization	(0.00%)	(3.50%)	(9.70%)
Unrealized foreign exchange losses	0.90%	6.00%	0.00%
Change in reserves for uncertain tax positions	(5.00%)	1.20%	(0.30%)
Non-taxable gains on acquisition of pre-existing ownership interests in HPPC and Empire	0.00%	0.00%	(1.30%)
Reduction of deferred tax liabilities resulting from change in United Kingdom tax rate	(2.10%)	(4.20%)	0.00%
Other	1.60%	1.30%	1.50%
Provision for income taxes	24.50%	59.90%	22.80%

Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Noncurrent deferred tax assets/(liabilities):
Basis difference on inventory	$ 10,933	$ 11,232
Reserves not currently deductible	23,757	17,652
Basis difference on intangible assets	(145,558)	(145,673)
Basis difference on property and equipment	(20,137)	(25,933)
Other comprehensive income	(768)	(4,623)
Net operating loss and tax credit carryforwards	22,197	25,340
Stock based compensation	3,996	4,632
Other	(616)
Other		1,176
Valuation allowances	(14,850)	(15,310)	$ (10,926)
Noncurrent deferred tax liabilities, net	(121,046)	(131,507)
Total net deferred tax liabilities	(121,046)	$ (131,507)
Non-current deferred tax assets	$ 429

Income Taxes (Changes in Valuation Allowances) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Valuation Allowance [Roll Forward]
Balance at beginning of year	$ 15,310	$ 10,926
Balance at end of year	14,850	15,310
Additions charged to income tax expense
Valuation Allowance [Roll Forward]
Change in valuation allowance	1,862	7,484
Reductions credited to income tax expense
Valuation Allowance [Roll Forward]
Change in valuation allowance	(1,922)	(2,417)
Currency translation adjustments
Valuation Allowance [Roll Forward]
Change in valuation allowance	$ (400)	$ (683)

Income Taxes (Unrecognized Tax Benefits Activity) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 16,019	$ 10,759	$ 11,058
Additions based on tax positions related to the current year	217	4,276	1,089
Additions based on tax positions related to prior years	0	1,404	202
Reductions due to lapse in statute of limitations and settlements	(4,634)	(420)	(1,590)
Balance at end of year	$ 11,602	$ 16,019	$ 10,759

Stockholders' Equity - Narrative (Details) - shares	Jun. 30, 2017	Jun. 30, 2016
Equity [Abstract]
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares outstanding	0	0

Stockholders' Equity - Accumulated Other Comprehensive Loss (Details) - USD ($)	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive (loss) income	$ (23,368,000)	$ (130,480,000)	$ (101,699,000)
Foreign currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(22,951,000)	(129,874,000)
Deferred gains/(losses) on cash flow hedging instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	196,000	4,666,000
Amounts reclassified into income	(575,000)	(5,193,000)
Reclassified into income, before taxes	1,233,000	6,788,000
Unrealized gain on available for sale investment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(51,000)	(79,000)
Amounts reclassified into income	13,000	0
Reclassified into income, before taxes	(21,000)	0
Intra-entity foreign currency transactions
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	$ 18,385,000	$ 107,221,000

Stock Based Compensation And Incentive Performance Plans (Stock Plans Narrative) (Details)	12 Months Ended
	Jun. 30, 2017 plan shares	Jun. 30, 2016 shares	Jun. 30, 2015 shares	Jun. 30, 2014 shares	Nov. 30, 2012 shares	Dec. 31, 2003 shares	May 31, 2000 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shareholder-approved plans \| plan	2
Equity instruments other than options, nonvested (in shares)	992,000	1,121,000	1,145,000	1,259,000
Number of shares available for grant	12,643,000
Options outstanding (in shares)	122,000	342,000	1,249,000	2,674,000
Long Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)				31,500,000
Awards denominated in shares of common stock other than options and stock appreciation rights, value again available share limit	2.07
Expiration period	7 years
Options granted in the period (in shares)	0	0	0
Equity instruments other than options granted in the period (in shares)	195,000	498,000	440,000
Equity instruments other than options, nonvested (in shares)	988,000
Number of shares available for grant	11,523,000
Options outstanding (in shares)	0
Long Term Incentive Plan \| Before Amendments
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)					3,200,000
Executive Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options granted in the period (in shares)		366,000	365,000
Executive Incentive Plan \| Subject To Achievement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options granted in the period (in shares)		284,000	109,000
Directors Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)						1,900,000
Expiration period	7 years
Options granted in the period (in shares)	0	0	0
Equity instruments other than options granted in the period (in shares)	0	0	20,000
Equity instruments other than options, nonvested (in shares)	4,000
Directors Stock Plan \| Before Amendments
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)							1,500,000
Prior Hain And Celestial Plans
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares)	122,000

Stock Based Compensation And Incentive Performance Plans (Compensation Cost And Related Income Tax Benefits Recognized) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Compensation cost (included in selling, general and administrative expense)	$ 9,658	$ 12,688	$ 12,197
Related income tax benefit	$ 3,622	$ 4,758	$ 4,695

Stock Based Compensation And Incentive Performance Plans (Summary Of Stock Option Activity) (Details) - $ / shares shares in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Outstanding
Outstanding at beginning of year (in shares)	342	1,249	2,674
Exercised (in shares)	(220)	(907)	(1,425)
Outstanding at end of the year (in shares)	122	342	1,249
Options exercisable at year end (in shares)	122	342	1,249
Weighted Average Exercise Price
Outstanding beginning of the year (USD per share)	$ 6.66	$ 6.12	$ 9.83
Exercised (USD per share)	9.10	5.91	13.08
Outstanding end of the year (USD per share)	2.26	6.66	6.12
Options exercisable at end of year (USD per share)	$ 2.26	$ 6.66	$ 6.12

Stock Based Compensation And Incentive Performance Plans (Schedule Of Cash Proceeds Received From Share-Based Payment Awards) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Intrinsic value of options exercised	$ 6,507	$ 27,147	$ 62,213
Cash received from stock option exercises	0	0	18,643
Tax benefit recognized from stock option exercises	$ 2,538	$ 10,587	$ 24,213

Stock Based Compensation And Incentive Performance Plans (Other Narrative) (Details)		1 Months Ended	12 Months Ended
	Jul. 03, 2012 USD ($) tranche target $ / shares shares	Oct. 31, 2015 USD ($) shares	Jun. 30, 2017 USD ($) condition shares	Jun. 30, 2016 USD ($) shares	Jun. 30, 2015 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value of outstanding options			$ 4,458,000
Weighted average remaining contractual life			14 years
Unrecognized compensation expense			$ 0
CEO Grant July 2012 granted (in shares) \| shares			12,643,000
CEO Grant July 2012 Total Fair Value			$ 6,567,000	$ 10,203,000	$ 16,462,000
Nonvested awards other than options, unrecognized cots			$ 12,117,000
Shares issued in the period (in shares) \| shares			195,000	416,000	311,000
Compensation expense, other than stock based equity or TSR grants			$ 4,044,000	$ (2,037,000)	$ 4,967,000
Long Term Incentive Plan 2015-2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award requisite service period			2 years
Long Term Incentive Plan 2016-2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award requisite service period			3 years
Conversion of common stock (in shares) \| shares			1
Long Term Incentive Plan 2014-2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
LTIP value settled after deducting initial equity grants		$ 4,400,000
Shares issued in the period (in shares) \| shares		82,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation costs not yet recognized, period for recognition			1 year 11 months
CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 granted (in shares) \| shares	800,000
Number of share price targets \| target	4
Consecutive trading days	45 days
Award vesting period	5 years
CEO Grant July 2012 Total Fair Value	$ 16,151,000
Compensation costs not yet recognized, period for recognition	4 years
Number of market conditions \| condition			4
Number of tranches \| tranche	4
CEO \| Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 granted (in shares) \| shares	200,000
CEO Grant July 2012 market price targets (in USD per share) \| $ / shares	$ 31.25
CEO \| Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 market price targets (in USD per share) \| $ / shares	36.25
CEO \| Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 market price targets (in USD per share) \| $ / shares	41.25
CEO \| Tranche Four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
CEO Grant July 2012 market price targets (in USD per share) \| $ / shares	$ 50

Stock Based Compensation And Incentive Performance Plans (Non-Vested Restricted Stock And Restricted Share Unit Awards) (Details) - $ / shares shares in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Number of Shares
Non-vested restricted stock and restricted share units - beginning of year (in shares)	1,121	1,145	1,259
Granted (in shares)	195	416	311
Vested (in shares)	(290)	(408)	(402)
Forfeited (in shares)	(34)	(32)	(23)
Non-vested restricted stock and restricted share units - end of year (in shares)	992	1,121	1,145
Weighted Average Grant Date Fair Value
Non-vested restricted stock and units - beginning of year, Weighted Average Grant Date Fair Value (USD per share)	$ 28.24	$ 32.30	$ 25.44
Granted (USD per share)	33.68	24.54	54.11
Vested (USD per share)	33.89	35.13	26.86
Forfeited (USD per share)	29.88	45.83	40.65
Non-vested restricted stock and units - end of year, Weighted Average Grant Date Fair Value (USD per share)	$ 27.59	$ 28.24	$ 32.30

Stock Based Compensation And Incentive Performance Plans (Restricted Stock Grant Information) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Fair value of restricted stock and restricted share units granted	$ 6,567	$ 10,203	$ 16,462
Fair value of shares vested	9,866	18,917	21,481
Tax benefit recognized from restricted shares vesting	$ 3,768	$ 7,139	$ 8,364

Investments And Joint Ventures (Equity Method Investments) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016	Oct. 27, 2015
Hutchison Hain Organic Holdings Limited
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	50.00%
Advances to affiliate	$ 1,629	$ 1,729
Chop't
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage			14.90%
Carrying value of investment	$ 16,487	$ 17,448
Percentage of diluted basis			11.90%

Investments And Joint Ventures (Available for Sale Securities) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Equity Method Investments and Joint Ventures [Abstract]
Percentage of ownership (less than)	1.00%
Sale of available for sale security (in shares)	102,000	0
Loss on sale of available for sale security	$ 21
Shares held (in shares)	933,000
Available for sale securities	$ 882	$ 1,067
Amortized cost basis, available for sale securities	$ 1,164	$ 1,291

Financial Instruments Measured At Fair Value (Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Assets:
Cash equivalents	$ 21,800	$ 20,706
Forward foreign currency contracts	99	531
Available for sale securities	882	1,067
Assets total	22,781	22,304
Liabilities:
Contingent consideration	2,656	3,553	$ 1,636
Forward foreign currency contracts	53
Total	2,709	3,553
Quoted prices in active markets (Level 1)
Assets:
Cash equivalents	21,800	20,706
Forward foreign currency contracts	0	0
Available for sale securities	882	1,067
Assets total	22,682	21,773
Liabilities:
Contingent consideration	0	0
Forward foreign currency contracts	0
Total	0	0
Significant other observable inputs (Level 2)
Assets:
Cash equivalents	0	0
Forward foreign currency contracts	99	531
Available for sale securities	0	0
Assets total	99	531
Liabilities:
Contingent consideration	0	0
Forward foreign currency contracts	53
Total	53	0
Significant unobservable inputs (Level 3)
Assets:
Cash equivalents	0	0
Forward foreign currency contracts	0	0
Available for sale securities	0	0
Assets total	0	0
Liabilities:
Contingent consideration	2,656	3,553
Forward foreign currency contracts	0
Total	$ 2,656	$ 3,553

Financial Instruments Measured At Fair Value (Narrative) (Details)					3 Months Ended		12 Months Ended
	Jun. 19, 2017 USD ($)	Apr. 28, 2017 GBP (£)	Sep. 15, 2016 GBP (£)	Feb. 20, 2015 CAD ($) period	Jun. 30, 2017 CAD ($)	Jun. 30, 2016 CAD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2016 CAD ($)	Dec. 21, 2015 GBP (£)
Business Acquisition [Line Items]
Contingent consideration paid							$ 3,969,000	$ 1,547,000
Derivative, notional amount							1,828,000	6,000,000
Fair value amounts of foreign exchange derivative contracts, net assets (liabilities)							$ 84,000	531,000
Foreign exchange contracts, maturities							2 months
Discontinued foreign exchange hedges							$ 0	$ 0
Not Designated as Hedging Instrument
Business Acquisition [Line Items]
Derivative, notional amount							6,114,000
Net liabilities							$ 38,000
Belvedere
Business Acquisition [Line Items]
Contingent consideration, high range				$ 4,000,000
Contingent consideration arrangements, number of periods for achievement operating results \| period				2
Contingent consideration arrangements, period for achievement operating results				1 year
Contingent consideration paid					$ 2,000,000	$ 2,000,000			$ 2,000,000
Orchard House
Business Acquisition [Line Items]
Contingent consideration paid \| £			£ 1,500,000
Business combination, contingent consideration \| £										£ 3,000,000
Better Bean
Business Acquisition [Line Items]
Contingent consideration, high range	$ 4,000,000
Contingent consideration arrangements, period for achievement operating results	3 years						3 years
Yorkshire Provender
Business Acquisition [Line Items]
Contingent consideration, high range \| £		£ 1,500,000
Contingent consideration arrangements, period for achievement operating results		3 years

Financial Instruments Measured At Fair Value (Summary Of Level 3 Activity) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of year	$ 3,553	$ 1,636
Fair value of initial contingent consideration	2,652	2,225
Contingent consideration adjustments	526	1,511
Contingent consideration paid	(3,969)	(1,547)
Translation adjustment	(106)	(272)
Balance at end of year	$ 2,656	$ 3,553

Commitments And Contingencies (Operating Lease Future Minimum Payments) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
2018	$ 18,771
2019	14,831
2020	12,615
2021	9,401
2022	8,516
Thereafter	37,702
Total	101,836
Rent expense	$ 34,028	$ 33,803	$ 29,560

(Legal Proceedings) (Details) - complaint				1 Months Ended
(Legal Proceedings) (Details) - complaint	Aug. 10, 2017	Apr. 26, 2017	Aug. 17, 2016	Dec. 29, 2016
Securities Complaints
Loss Contingencies [Line Items]
Number of complaints			3
Derivative Complaints
Loss Contingencies [Line Items]
Number of complaints				2
Barnes Complaint
Loss Contingencies [Line Items]
Number of complaints		2
Barnes Complaint \| Subsequent Event
Loss Contingencies [Line Items]
Litigation response period	60 days

Defined Contribution Plans (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Retirement Benefits [Abstract]
Defined contribution plan eligibility minimum days worked	30 days
Defined contribution plan, costs	$ 1,367	$ 1,236	$ 1,090

Segment Information (Narrative) (Details) - segment	12 Months Ended
Segment Information (Narrative) (Details) - segment	Jun. 30, 2017	Jun. 30, 2016
Segment Reporting [Abstract]
Number of operating segments		7
Number of reportable segments	8

Segment Information (Segment Data) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Segment Reporting Information [Line Items]
Net Sales									$ 2,853,111	$ 2,885,374	$ 2,609,613
Operating Income	$ 8,587	$ 47,067	$ 41,400	$ 13,751	$ (65,138)	$ 71,148	$ 90,078	$ 54,272	110,805	150,360	233,862
Acquisition and restructuring charges									10,388	12,065	7,244
Long-lived asset and intangibles impairment					39,724				40,452	43,200	1,004
Accounting review costs	9,473	$ 7,124	$ 7,005	$ 5,960					29,562	0	0
Goodwill impairment									$ 0	84,548	$ 0
Exit from Chilled Desserts
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment										$ 3,476
Sales \| Customer Concentration Risk \| First Customer
Segment Reporting Information [Line Items]
Concentration risk, percentage									10.00%	10.00%	10.00%
Sales \| Customer Concentration Risk \| Second Customer
Segment Reporting Information [Line Items]
Concentration risk, percentage									9.00%	10.00%	11.00%
United States
Segment Reporting Information [Line Items]
Goodwill impairment										$ 0
United Kingdom
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment	$ 26,373								$ 26,373
Goodwill impairment					$ 84,548					84,548
Hain Pure Protein
Segment Reporting Information [Line Items]
Goodwill impairment										0
Rest of World
Segment Reporting Information [Line Items]
Goodwill impairment										0
Operating Segments
Segment Reporting Information [Line Items]
Net Sales									2,853,111	2,885,374	$ 2,609,613
Operating Income									230,647	318,937	276,934
Operating Segments \| United States
Segment Reporting Information [Line Items]
Net Sales									1,191,262	1,249,123	1,253,156
Operating Income									157,506	203,481	180,937
Operating Segments \| United Kingdom
Segment Reporting Information [Line Items]
Net Sales									768,301	774,877	722,830
Operating Income									39,749	56,000	44,985
Operating Segments \| Hain Pure Protein
Segment Reporting Information [Line Items]
Net Sales									509,606	492,510	337,197
Operating Income									1,382	31,558	28,685
Operating Segments \| Rest of World
Segment Reporting Information [Line Items]
Net Sales									383,942	368,864	296,430
Operating Income									32,010	27,898	22,327
Corporate and Other
Segment Reporting Information [Line Items]
Operating Income									(119,842)	(168,577)	$ (43,072)
Long-lived asset and intangibles impairment									14,079	39,724
Corporate and Other \| United States
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment									6,500	18,792
Corporate and Other \| United Kingdom
Segment Reporting Information [Line Items]
Long-lived asset and intangibles impairment									$ 7,579	20,932
Goodwill impairment										$ 84,548

Segment Information (Net Sales) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Revenue from External Customer [Line Items]
Net Sales	$ 2,853,111	$ 2,885,374	$ 2,609,613
United States
Revenue from External Customer [Line Items]
Net Sales	1,677,294	1,729,751	1,582,553
United Kingdom
Revenue from External Customer [Line Items]
Net Sales	851,757	859,183	803,470
All Other
Revenue from External Customer [Line Items]
Net Sales	324,060	296,440	223,590
Grocery
Revenue from External Customer [Line Items]
Net Sales	1,743,860	1,800,640	1,724,675
Poultry/Protein
Revenue from External Customer [Line Items]
Net Sales	509,606	492,510	337,197
Snacks
Revenue from External Customer [Line Items]
Net Sales	312,784	307,797	291,719
Personal Care
Revenue from External Customer [Line Items]
Net Sales	176,408	171,669	135,627
Tea
Revenue from External Customer [Line Items]
Net Sales	$ 110,453	$ 112,758	$ 120,395

Segment Information (Long-lived Assets) (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
Segment Reporting Information [Line Items]
Long lived assets	$ 423,074	$ 442,723
United States
Segment Reporting Information [Line Items]
Long lived assets	194,348	193,192
United Kingdom
Segment Reporting Information [Line Items]
Long lived assets	165,396	196,271
All Other
Segment Reporting Information [Line Items]
Long lived assets	$ 63,330	$ 53,260

Quarterly Financial Data (Unaudited) (Schedule of Quarterly Data) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Quarterly Financial Information Disclosure [Abstract]
Net sales	$ 725,085	$ 706,563	$ 739,999	$ 681,464	$ 737,547	$ 736,663	$ 743,437	$ 667,727	$ 2,853,111	$ 2,885,374	$ 2,609,613
Gross profit	149,719	143,393	138,393	109,867	150,081	159,908	166,261	137,881	541,372	614,131	562,855
Operating income (loss)	8,587	47,067	41,400	13,751	(65,138)	71,148	90,078	54,272	110,805	150,360	233,862
Income/(loss) before income taxes and equity in earnings of equity-method investees	2,749	39,556	37,656	9,182	(77,572)	72,863	80,713	42,404	89,143	118,408	212,869
Net income (loss)	$ 313	$ 31,328	$ 27,185	$ 8,604	$ (88,597)	$ 48,788	$ 58,080	$ 29,158	$ 67,430	$ 47,429	$ 164,962
Net income (loss) per common share:
Basic (USD per share)	$ 0.00	$ 0.30	$ 0.26	$ 0.08	$ (0.86)	$ 0.47	$ 0.56	$ 0.28	$ 0.65	$ 0.46	$ 1.62
Diluted (USD per share)	$ 0.00	$ 0.30	$ 0.26	$ 0.08	$ (0.86)	$ 0.47	$ 0.56	$ 0.28	$ 0.65	$ 0.46	$ 1.60

Quarterly Financial Data (Unaudited) (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended						12 Months Ended
	Oct. 25, 2014	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Effect of Fourth Quarter Events [Line Items]
Long-lived asset and intangibles impairment						$ 39,724		$ 40,452	$ 43,200	$ 1,004
Intangibles impairment, net						30,772
Accounting review costs		$ 9,473	$ 7,124	$ 7,005	$ 5,960			29,562	0	0
Accounting review costs, net		6,773	$ 5,029	$ 5,050	$ 4,112
Goodwill impairment								0	84,548	0
Impairment charge related to long-lived assets		23,712								1,004
Gain on fire insurance recovery								0	9,752	$ 0
Tilda Milling Facility Fire
Effect of Fourth Quarter Events [Line Items]
Gain on fire insurance recovery	$ 9,752						$ 9,013
Gain on fire insurance recovery, net							$ 6,231
Orchard House
Effect of Fourth Quarter Events [Line Items]
Goodwill impairment									1,934
United Kingdom
Effect of Fourth Quarter Events [Line Items]
Long-lived asset and intangibles impairment		26,373						26,373
Intangibles impairment, net		20,877
Goodwill impairment						84,548			84,548
United Kingdom \| Orchard House
Effect of Fourth Quarter Events [Line Items]
Impairment charge related to long-lived assets									$ 3,476
Impairment charge related to long-lived assets, net						$ 2,855
Trade Names
Effect of Fourth Quarter Events [Line Items]
Long-lived asset and intangibles impairment		14,079						$ 14,079
Intangibles impairment, net		$ 10,733

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Allowance for doubtful accounts
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 936	$ 896	$ 1,586
Charged to costs and expenses	1,077	208	791
Charged to other accounts	149	54	20
Deductions	(715)	(222)	(1,501)
Balance at end of period	1,447	936	896
Valuation allowance for deferred tax assets
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	15,310	10,926	10,952
Charged to costs and expenses	1,862	7,484	963
Charged to other accounts	0	0	0
Deductions	(2,322)	(3,100)	(989)
Balance at end of period	$ 14,850	$ 15,310	$ 10,926